Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

AB1_VIRAL_HEMOR_FEVER_NOS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A98, A99 Hospital discharge: ICD-10 — A98, A99 Hospital discharge: ICD-9 — 06[6] Hospital discharge: ICD-8 — 06[7] Cause of death: ICD-10 — A98, A99 Cause of death: ICD-9 — 06[6] Cause of death: ICD-8 — 06[7] 3 out of 7 registries used, show all original rules.	7696
4. Check minimum number of events None	7696
5. Include endpoints None	7696
6. Filter based on genotype QC (FinnGen only)	6913

Control definitions (FinnGen only)

Control exclude: AB1_ARTHROPOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF13

NAME	AB1_VIRAL_HEMOR_FEVER_NOS_WIDE
CONTROL_EXCLUDE	AB1_ARTHROPOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A9[8-9]
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A9[8-9]
HD_ICD_9	06[6]
HD_ICD_8	06[7]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A9[8-9]
COD_ICD_9	06[6]
COD_ICD_8	06[7]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6913	3731	3182
Unadjusted period prevalence (%)	1.39	1.32	1.46
Median age at first event (years)	56.02	54.14	58.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7176: Matched controls
71709

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1336

SPAT

Request for examination

7.6

307.7

736

1064

A98

ICD-10 Finland

Other viral haemorrhagic fevers, not elsewhere classified

+∞

307.7

3155

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

+∞

307.7

3944

R50.9

ICD-10 Finland

Fever, unspecified

2.7

248.8

1627

6935

B60

ICPC

Blood and Immunity, Result test/procedure

10.3

225.2

254

EB1SA, ,

SPAT

4.0

221.5

681

1835

A60

ICPC

General and Unspecified, Result test/procedure

4.4

219.1

585

1419

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.3

205.9

853

2797

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

3.4

193.8

753

2369

WX110, ,

SPAT

3.5

187.5

688

2085

EB1AA, ,

SPAT

3.3

180.1

747

2444

L28

ICPC

Limited function/disability (L)

2.3

170.6

1663

8361

T45

ICPC

Metabolic, Observ/health educat/advice/diet

7.1

167.9

258

377

A97

ICPC

No disease

2.2

165.3

1850

9823

W78

ICD-10 Finland

Inhalation of gastric contents

32.0

151.5

A03

ICPC

Fever

2.2

150.6

1613

8377

D62

ICPC

Digestive, Administrative procedure

14.6

145.8

131

A62

ICPC

General and Unspecified, Administrative procedure

4.7

143.3

340

747

QAE99, ,

SPAT

8.0

138.4

190

244

L48

ICPC

Musculoskeletal, Clarification/discussion RFE/demand

8.0

135.9

186

238

A99

ICPC

Disease/condition unspecnature/site

2.5

134.8

1002

4435

K43

ICPC

Cardiovascular, Other diagnostic procedure

7.8

129.3

180

235

EBA00, ,

SPAT

4.3

128.5

341

818

L17, ,

ICD-10 Finland

20.2

128.1

Z2221

NOMESCO Finland

Medical doctor

1.9

122.8

2140

13096

K48

ICPC

Cardiovascular, Clarification/discussion RFE/demand

12.1

121.7

122

102

SPAT1342

SPAT

Referral to specialised care

6.7

120.2

193

295

T60

ICPC

Metabolic, Result test/procedure

8.2

120.2

160

198

R4110

NOMESCO Finland

Physiotherapy

1.9

118.6

2210

13787

T90

ICD-10 Finland

Sequelae of injuries of head

21.0

112.8

R48

ICPC

Respiratory, Clarification/discussion RFE/demand

9.8

111.9

130

135

QBE99, ,

SPAT

7.5

110.7

160

218

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

105.1

2749

18820

Z3231

NOMESCO Finland

Registered nurse

1.8

100.7

2092

13364

T69

ICPC

Metabolic, Other reason for encounter NEC

9.8

100.1

116

120

S48

ICPC

Skin, Clarification/discussion RFE/demand

10.5

98.1

108

104

WX290, ,

SPAT

3.4

97.4

364

1107

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.3

93.3

777

3584

SPAT1283

SPAT

Restricted health certificate

1.9

90.3

1318

7503

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

3.3

87.3

348

1101

WZA30, ,

SPAT

7.4

87.0

127

175

Z3226

NOMESCO Finland

Physiotherapist

1.9

86.9

1397

8196

SPAT1325

SPAT

Vaccination

1.7

84.8

2357

16170

T31

ICPC

Metabolic, Medical examin/health eval partial

7.1

84.8

128

183

T62

ICPC

Metabolic, Administrative procedure

12.8

82.7

A61

ICPC

General and Unspecified, Result examination/test/record/letter from other provider

6.8

82.4

129

192

S29

ICPC

Skin symptom/complaint other

1.8

82.1

1601

9942

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

80.3

3415

25937

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

78.4

2498

17662

TNB11, ,

SPAT

9.4

78.0

100

S29

ICD-10 Finland

Other and unspecified injuries of thorax

22.6

76.6

L17

ICPC

Foot/toe symptom/complaint

1.6

74.9

2273

15839

T48

ICPC

Metabolic, Clarification/discussion RFE/demand

9.3

73.0

R05

ICPC

Cough

1.7

72.0

1885

12628

ZXE00

NOMESCO Finland

One hour or less

1.6

71.3

2702

19799

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

68.3

1209

7252

M79.6

ICD-10 Finland

Pain in limb

1.5

67.9

3148

24064

S56

ICPC

Skin, Dressing/pressure/compress/tamponade

6.6

66.5

107

164

D06

ICPC

Abdominal pain localized other

2.1

66.0

734

3774

D83

ICPC

Mouth/tongue/lip disease

4.8

64.5

145

304

F43

ICPC

Eye, Other diagnostic procedure

3.6

64.2

216

613

D48

ICPC

Digestive, Clarification/discussion RFE/demand

11.5

63.7

N02AX02

ATC

tramadol; systemic, rectal

1.5

63.2

2950

22467

S18

ICD-10 Finland

Traumatic amputation at neck level

16.2

62.3

N43

ICPC

Neurological, Other diagnostic procedure

12.9

62.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

62.1

1304

8193

L02

ICPC

Back symptom/complaint

2.0

62.0

802

4343

K60

ICPC

Cardiovascular, Result test/procedure

6.6

61.8

151

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

60.9

1096

6587

S21

ICPC

Skin texture symptom/complaint

1.8

60.1

1152

7049

U60

ICPC

Urological, Result test/procedure

7.6

58.8

110

A99

ICD-10 Finland

Unspecified viral haemorrhagic fever

+∞

58.4

N02BE01

ATC

paracetamol; systemic, rectal

1.8

58.3

6282

57046

L12

ICPC

Hand/finger symptom/complaint

1.7

56.9

1288

8236

M54.5

ICD-10 Finland

Low back pain

1.5

55.8

2570

19376

D19

ICPC

Teeth/gum symptom/complaint

1.5

54.6

2204

16143

S21

ICD-10 Finland

Open wound of thorax

17.7

54.1

UJF32, ,

SPAT

2.7

53.9

302

1153

TNG11, ,

SPAT

7.9

53.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

52.7

3525

28510

N01

ICPC

Headache

1.8

52.5

862

5024

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

52.3

2541

19299

Z71.8

ICD-10 Finland

Other specified counselling

1.5

51.8

2425

18271

ZXA05

NOMESCO Finland

Left side

1.6

50.8

1585

10934

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.8

50.4

251

901

WX002

NOMESCO Finland

Sedation and analgesia

1.6

50.3

1291

8497

T66

ICPC

Metabolic, Referral to non-MD provider

8.9

50.1

JFA15, ,

SPAT

5.3

49.1

189

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

48.1

939

5747

SPAT1192

SPAT

Gynaecological examination

2.0

47.9

588

3118

H51

ICPC

Ear, I&d/flush/aspiration

4.0

47.8

137

348

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

47.2

295

1188

R07

ICPC

Sneezing/nasal congestion

2.0

47.1

508

2573

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

46.5

1259

8377

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

45.8

438

2120

R52.9

ICD-10 Finland

Pain, unspecified

1.8

45.7

753

4385

B44

ICPC

Blood and Immunity, Preventive immunization/medic

8.2

45.2

TNX00, ,

SPAT

4.0

44.8

130

333

D82

ICPC

Teeth/gum disease

1.4

44.7

2567

19970

S50

ICPC

Skin, Medication/prescr/renewal

5.3

44.6

172

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

4.9

44.6

198

U48

ICPC

Urological, Clarification/discussion RFE/demand

9.4

44.4

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

44.3

446

2201

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

43.7

440

2170

F48

ICPC

Eye, Clarification/discussion RFE/demand

12.8

43.4

A98

ICPC

Health maint/preventive medicine

2.7

43.2

6983

66718

U07

ICPC

Urine symptom/complaint other

1.9

42.8

616

3439

WZB00, ,

SPAT

1.8

42.8

679

3907

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

42.8

760

4521

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.6

41.6

138

388

R02

ICPC

Shortness of breath/dyspnoea

1.7

41.6

942

5984

U01

ICPC

Dysuria/painful urination

1.9

40.1

561

3100

W90

ICD-10 Finland

Exposure to other nonionizing radiation

88.5

39.8

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.2

39.6

162

520

D11

ICPC

Diarrhoea

1.7

39.2

848

5317

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.3

39.1

303

1345

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

39.1

1875

14027

ZXA00

NOMESCO Finland

Right side

1.5

39.1

1638

11939

ZXD20

NOMESCO Finland

Day surgery

1.7

38.8

830

5188

R4120

NOMESCO Finland

Occupational therapy

2.0

38.8

476

2519

TQW40, ,

SPAT

1.7

38.6

714

4291

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

38.5

254

1050

SCF01

NOMESCO Finland

Preventive oral care by dental hygienist or dental assistant, restricted

2.5

38.5

249

1020

A28

ICPC

Limited function/disability NOS

1.6

37.9

1120

7572

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

37.8

463

2448

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.4

37.0

270

1168

T30

ICPC

Metabolic, Medical examin/health eval complete

6.8

36.8

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

36.7

273

1191

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

36.4

241

997

ZY010

NOMESCO Finland

Hospital outpatient

2.0

36.4

387

1946

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

36.4

1270

8899

J01DB01

ATC

cefalexin; oral

1.5

35.8

5695

51929

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

35.4

1239

8680

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.7

35.4

200

767

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

35.0

369

1851

R51.80

ICD-10 Finland

Headache

1.6

34.8

1058

7186

L12

ICD-10 Finland

Pemphigoid

12.2

34.1

J01FA06

ATC

roxithromycin; oral

1.4

33.9

2464

19718

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

33.7

154

528

D01

ICPC

Abdominal pain/cramps general

1.6

33.5

861

5623

EBA05, ,

SPAT

3.0

33.4

146

488

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.7

33.3

179

670

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.6

33.2

192

745

R06.0

ICD-10 Finland

Dyspnoea

1.4

33.2

1747

13224

XF400, ,

SPAT

3.9

33.1

255

U02

ICPC

Urinary frequency/urgency

1.6

32.7

959

6458

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

32.6

362

1849

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

32.3

258

1161

M25.5

ICD-10 Finland

Pain in joint

1.4

32.1

2166

17089

SPAT1213

SPAT

Examination of postural anomaly

3.3

31.7

119

363

UJD10, ,

SPAT

2.5

31.5

202

824

Z2446

NOMESCO Finland

Social worker

1.8

31.4

460

2577

R03AC02

ATC

salbutamol; inhalant

1.3

31.3

3610

30881

M03BX02

ATC

tizanidine; oral

1.3

31.3

4052

35260

R42

ICD-10 Finland

Dizziness and giddiness

1.4

31.2

1446

10678

D09

ICPC

Nausea

2.0

31.2

342

1739

QDE99, ,

SPAT

6.0

31.0

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.4

30.7

208

871

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

30.5

912

6159

N17

ICPC

Vertigo/dizziness

1.6

30.5

837

5545

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

30.3

309

1531

J20

ICD-10 Finland

Acute bronchitis

1.6

30.2

684

4326

QCE99, ,

SPAT

7.1

30.0

R53

ICD-10 Finland

Malaise and fatigue

1.4

29.9

1630

12377

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

29.6

2847

23645

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

29.5

319

1614

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

29.1

1645

12560

A02BC02

ATC

pantoprazole; systemic

1.3

28.8

4493

39922

K02

ICD-10 Finland

Dental caries

1.8

28.6

456

2618

M54

ICD-10 Finland

Dorsalgia

1.6

28.6

823

5506

F29

ICPC

Eye symptom/complaint other

1.6

28.4

715

4639

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

28.4

1397

10409

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

28.3

526

3155

J01MA02

ATC

ciprofloxacin; systemic

1.3

28.0

2417

19715

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

27.6

1415

10614

R60

ICPC

Respiratory, Result test/procedure

6.7

27.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

27.2

809

5448

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

27.2

335

1773

H29

ICPC

Ear symptom/complaint other

1.5

27.1

796

5346

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

27.1

4875

43996

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

27.1

1337

9955

R05

ICD-10 Finland

Cough

1.4

27.1

1407

10571

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

26.9

614

3888

A04

ICPC

Weakness/tiredness general

1.5

26.7

1025

7280

M01AH05

ATC

etoricoxib; oral

1.3

26.6

4053

35688

TND11, ,

SPAT

10.0

26.5

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

26.2

2456

20216

A98.8

ICD-10 Finland

Other specified viral haemorrhagic fevers

+∞

26.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

25.9

1559

11994

R21

ICPC

Throat symptom/complaint

1.4

25.8

1376

10377

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.8

25.5

124

441

L15

ICPC

Knee symptom/complaint

1.4

25.4

1597

12368

H01

ICPC

Ear pain/earache

1.5

25.3

798

5439

B48

ICPC

Blood and Immunity, Clarification/discussion RFE/demand

10.4

25.3

WX105, ,

SPAT

3.8

25.1

197

L05

ICPC

Flank/axilla symptom/complaint

1.8

25.0

427

2500

H81

ICD-10 Finland

Disorders of vestibular function

7.6

25.0

L08

ICPC

Shoulder symptom/complaint

1.4

24.9

1479

11345

Z2445

NOMESCO Finland

Psychologist

2.0

24.8

278

1425

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

24.7

1243

9271

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

24.4

379

2160

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

24.3

671

4440

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

5.7

24.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

23.9

461

2792

P76

ICPC

Depressive disorder

1.7

23.8

429

2550

SAA01, ,

SPAT

3.4

23.8

247

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

23.7

323

1767

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

23.5

235

1156

L13

ICD-10 Finland

Other bullous disorders

9.7

23.2

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

23.2

4849

44109

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

23.1

1875

15064

M01AB05

ATC

diclofenac; systemic, rectal

1.3

23.1

4228

37790

P01AB01

ATC

metronidazole; oral, rectal

1.3

23.0

2427

20210

L60

ICPC

Musculoskeletal, Result test/procedure

6.5

23.0

A04

ICD-10 Finland

Other bacterial intestinal infections

9.1

22.9

L03

ICPC

Low back symptom/complaint

1.3

22.8

1863

14976

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

22.7

656

4384

WX902

NOMESCO Finland

External defibrillation of heart

5.6

22.5

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

22.4

742

5107

A01

ICPC

Pain general/multiple sites

1.5

22.3

637

4246

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

22.1

2762

23482

S22

ICPC

Nail symptom/complaint

1.7

22.1

438

2673

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

22.0

948

6868

J01CA04

ATC

amoxicillin; systemic

1.3

21.7

5543

51513

B81

ICD-10 Finland

Other intestinal helminthiases, not elsewhere classified

38.7

21.7

L04

ICPC

Chest symptom/complaint

1.7

21.6

414

2503

G44.2

ICD-10 Finland

Tension-type headache

1.5

21.6

827

5857

IEY01

NOMESCO Finland

Psychoeducation, individual

3.7

21.4

182

N06AX21

ATC

duloxetine; oral

1.5

21.4

725

5012

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

21.3

1560

12319

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

21.3

1378

10682

UJD02

NOMESCO Finland

Gastroscopy

1.9

21.2

286

1561

R3110

NOMESCO Finland

Psychosocial training

3.1

21.2

292

X48

ICPC

Female Genital, Clarification/discussion RFE/demand

7.0

21.2

RK323, ,

NOMESCO Finland

5.7

21.1

A11

ICPC

Chest pain NOS

1.6

20.9

542

3535

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.9

20.8

276

1499

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

20.7

1519

11997

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.6

20.6

118

457

N03AX12

ATC

[U] gabapentin; oral

1.4

20.5

956

7014

B01AB05

ATC

enoxaparin; parenteral

1.3

20.4

1878

15301

D12

ICPC

Constipation

1.9

20.4

243

1273

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

20.4

775

5479

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

20.3

872

6304

OAB30, ,

SPAT

3.1

20.3

268

M54.8

ICD-10 Finland

Other dorsalgia

1.8

20.1

295

1653

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

20.0

773

5480

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

19.9

1738

14055

A08

ICPC

Swelling

1.7

19.8

354

2099

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.4

19.8

135

569

SPAT1016

SPAT

Examination of vision

1.8

19.7

301

1706

TDA90, ,

SPAT

1.6

19.5

434

2726

J45

ICD-10 Finland

Asthma

1.5

19.5

633

4334

H48

ICPC

Ear, Clarification/discussion RFE/demand

6.8

19.5

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

19.5

2147

17891

J01AA02

ATC

doxycycline; systemic

1.3

19.4

5000

46056

K03.00

ICD-10 Finland

Approximal wear

1.6

19.4

495

3215

A02BC01

ATC

omeprazole; systemic

1.3

19.3

1596

12802

L03

ICD-10 Finland

Cellulitis

3.0

19.3

287

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

19.2

1595

12799

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

19.2

1099

8344

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

19.2

460

2944

AA1AD

NOMESCO Finland

CT of head and brain

1.3

19.1

1725

13999

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

18.9

302

1735

K02.1

ICD-10 Finland

Caries of dentine

1.3

18.8

3871

34665

XX1VW, ,

SPAT

3.4

18.8

204

TNG10, ,

SPAT

5.1

18.8

R4190, ,

SPAT

3.8

18.8

152

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

18.8

1187

9151

R74

ICPC

Upper respiratory infection acute

1.3

18.7

2081

17338

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

18.7

1828

14987

A02BC03

ATC

lansoprazole; oral

1.3

18.7

1629

13154

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

18.4

425

2695

P03

ICPC

Feeling depressed

1.5

18.4

611

4202

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.3

18.4

138

607

P06

ICPC

Sleep disturbance

1.4

18.3

798

5779

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

18.2

128

547

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

18.2

6105

57919

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

18.1

1325

10433

S20

ICPC

Corn/callosity

2.3

18.1

139

617

C07AB07

ATC

bisoprolol; oral

1.3

18.1

2890

25114

D10

ICPC

Vomiting

1.7

18.1

374

2308

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

18.1

211

1099

K78

ICPC

Atrial fibrillation/flutter

1.6

18.0

436

2795

SDA04, ,

SPAT

5.0

18.0

L13

ICPC

Hip symptom/complaint

1.4

18.0

1139

8779

S97

ICD-10 Finland

Crushing injury of ankle and foot

52.6

17.9

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

17.8

1400

11135

N06AX11

ATC

mirtazapine; oral

1.3

17.7

2066

17292

J01

ICD-10 Finland

Acute sinusitis

1.7

17.7

344

2088

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

17.5

3723

33337

A46

ICD-10 Finland

Erysipelas

1.4

17.5

873

6474

C10AA01

ATC

simvastatin; oral

1.3

17.4

2343

19935

R29

ICPC

Respiratory symptom/complaint other

1.6

17.4

424

2722

QAA25, ,

SPAT

3.9

17.3

133

R09

ICPC

Sinus symptom/complaint

1.5

17.3

491

3264

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

17.3

1055

8079

M79.1

ICD-10 Finland

Myalgia

1.4

17.2

904

6762

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

17.1

4446

40639

J01FA09

ATC

clarithromycin; systemic

1.3

17.1

1851

15336

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

17.1

1414

11315

OAB31, ,

SPAT

5.0

17.1

B50

ICPC

Blood and Immunity, Medication/prescr/renewal

5.4

17.1

TLC00, ,

SPAT

2.2

17.0

149

699

P76

ICD-10 Finland

Other intestinal obstruction of newborn

50.1

17.0

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

16.9

1641

13411

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

16.8

1837

15232

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

16.8

632

4453

K39

ICPC

Cardiovascular, Physical function test

5.7

16.8

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

16.7

897

6731

WX402

NOMESCO Finland

General anaesthesia

1.3

16.7

1404

11260

K03.8

ICD-10 Finland

Other specified diseases of hard tissues of teeth

15.0

16.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

16.5

526

3583

R60.0

ICD-10 Finland

Localized oedema

1.4

16.5

745

5426

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

16.4

570

3953

R43

ICPC

Respiratory, Other diagnostic procedure

3.5

16.4

162

WVA20, ,

SPAT

1.8

16.3

236

1317

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.1

16.2

145

685

A05

ICPC

Feeling ill

1.6

16.2

375

2381

J01DA01

ATC

[U] cefalexin

1.2

16.1

3774

34018

P01

ICD-10 Finland

Fetus and newborn affected by maternal complications of pregnancy

24.5

16.0

W85

ICD-10 Finland

Exposure to electric transmission lines

24.5

16.0

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

16.0

764

5621

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.6

15.9

331

R07.3

ICD-10 Finland

Other chest pain

1.4

15.9

613

4340

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

15.8

3514

31473

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.0

15.8

179

924

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

15.7

2586

22435

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.7

15.7

304

K30

ICD-10 Finland

Functional dyspepsia

1.4

15.7

668

4812

SFA20

NOMESCO Finland

Two-surface restoration

1.2

15.7

3763

33950

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

15.6

1221

9682

N03AX16

ATC

[U] pregabalin

1.3

15.6

1321

10588

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

15.6

269

1581

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

15.6

413

2705

M02AA07

ATC

piroxicam; topical

1.3

15.6

2013

17003

H81

ICPC

Excessive ear wax

1.3

15.5

1031

7990

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

15.5

793

5899

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

15.5

1271

10148

J01FA10

ATC

azithromycin; systemic

1.2

15.4

3591

32280

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

15.3

1889

15861

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

15.1

390

2540

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.8

15.0

229

1299

C08CA01

ATC

amlodipine; oral

1.2

15.0

2249

19290

R06AX27

ATC

desloratadine; oral

1.3

15.0

1752

14611

X21

ICPC

Breast sympt/compl female other

2.2

14.9

129

602

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

14.9

474

3229

N02BF01

ATC

gabapentin; oral

1.4

14.9

623

4475

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.3

14.8

115

514

F73

ICPC

Eye infection/inflammation other

2.1

14.8

140

677

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

14.8

987

7650

E0000UV, ,

ATC

1.2

14.8

2587

22552

X15

ICPC

Vaginal symptom/complaint other

1.8

14.8

228

1299

K31

ICPC

Cardiovascular, Medical examin/health eval partial

3.6

14.7

130

D11

ICD-10 Finland

Benign neoplasm of major salivary glands

18.4

14.7

K62

ICPC

Cardiovascular, Administrative procedure

13.2

14.6

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

14.5

322

4976

SFA30

NOMESCO Finland

Three-surface restoration

1.2

14.5

2600

22712

R06AE07

ATC

cetirizine; oral

1.2

14.5

2677

23455

RK250, ,

NOMESCO Finland

3.7

14.4

118

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

14.3

1674

13951

R02

ICD-10 Finland

Gangrene, not elsewhere classified

5.0

14.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

14.2

521

3652

SDA05

NOMESCO Finland

Very demanding periodontal treatment

1.5

14.2

439

2974

L15, ,

ICD-10 Finland

13.4

14.2

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.2

14.2

115

524

WVA20

NOMESCO Finland

Medicine administration

1.9

14.1

176

939

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

14.1

143

711

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

4.2

14.0

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

14.0

544

3853

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

14.0

1497

12342

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

14.0

792

5986

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

13.9

324

2061

Z37.0

ICD-10 Finland

Single live birth

1.5

13.9

386

2556

K05.3

ICD-10 Finland

Chronic periodontitis

1.6

13.8

284

1750

WYA30, ,

SPAT

3.1

13.8

181

K08.80

ICD-10 Finland

Toothache NOS

1.4

13.8

523

3689

A97

ICD-10 Finland

Dengue

20.0

13.7

R2110

NOMESCO Finland

Giving the first information

1.5

13.7

369

2425

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

13.7

898

6937

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

13.6

326

2086

A98.0

ICD-10 Finland

Crimean-Congo haemorrhagic fever

+∞

13.5

SFA10

NOMESCO Finland

One-surface restoration

1.2

13.5

3518

31794

H25.8

ICD-10 Finland

Other senile cataract

0.6

13.5

258

4129

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

13.5

211

1208

J11

ICD-10 Finland

Influenza, virus not identified

2.3

13.5

408

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

13.5

702

5234

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

13.4

1407

11567

S15

ICPC

Foreign body in skin

1.5

13.4

383

2552

K85

ICPC

Elevated blood pressure

1.3

13.4

943

7361

T61

ICPC

Metabolic, Result examination/test/record/letter from other provider

18.2

13.3

Z01.2

ICD-10 Finland

Dental examination

1.2

13.3

2972

26460

F32

ICD-10 Finland

Depressive episode

1.6

13.3

302

1909

W92

ICD-10 Finland

Exposure to excessive heat of man-made origin

4.8

13.3

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

13.2

518

3676

N30

ICD-10 Finland

Cystitis

1.5

13.1

454

3145

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

13.1

254

1542

N17

ICD-10 Finland

Acute renal failure

4.9

13.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

13.0

744

5626

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

13.0

1297

10594

M54.3

ICD-10 Finland

Sciatica

1.6

13.0

342

2239

ZXA10

NOMESCO Finland

Bilateral

1.3

13.0

1014

8027

U07

ICD-10 Finland

Emergency use of U07

19.0

12.9

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

12.7

1713

14474

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.5

12.7

349

2305

B43

ICPC

Blood and Immunity, Other diagnostic procedure

5.8

12.7

J01FF01

ATC

clindamycin; systemic

1.2

12.7

1558

13033

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

12.6

811

6243

R31

ICD-10 Finland

Unspecified haematuria

1.4

12.5

552

4000

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

12.5

193

1101

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

12.5

329

2153

A85

ICPC

Adverse effect medical agent

2.5

12.5

288

U02, ,

ICD-10 Finland

130.1

12.4

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

12.4

527

3795

N05AH04

ATC

quetiapine; oral

1.3

12.3

1016

8094

P01

ICPC

Feeling anxious/nervous/tense

1.3

12.3

732

5573

M54.2

ICD-10 Finland

Cervicalgia

1.4

12.2

468

3307

R01AD09

ATC

mometasone; nasal

1.2

12.2

2754

24478

A39

ICPC

General and Unspecified, Physical function test

5.5

12.1

M53

ICD-10 Finland

Other dorsopathies, not elsewhere classified

2.9

12.1

185

P20

ICD-10 Finland

Intrauterine hypoxia

21.3

12.0

R12

ICD-10 Finland

Heartburn

1.4

12.0

486

3472

UJH02

NOMESCO Finland

Anoscopy

1.7

11.9

221

1327

WZA00

NOMESCO Finland

Concise certificate

1.5

11.9

374

2542

Z34

ICD-10 Finland

Supervision of normal pregnancy

1.8

11.9

190

1095

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

11.9

642

4811

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.4

11.9

331

S22

ICD-10 Finland

Fracture of rib(s), sternum and thoracic spine

4.4

11.9

N07BA03

ATC

varenicline; oral

1.6

11.8

272

1725

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

11.8

715

5453

H04

ICPC

Ear discharge

1.7

11.8

196

1142

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

11.8

536

3904

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

2.3

11.8

363

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.8

11.8

188

1084

M01AE02

ATC

naproxen; oral, rectal

1.2

11.8

3492

31776

W31

ICPC

Pregnancy, Medical examin/health eval partial

2.7

11.8

238

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.9

11.8

141

744

K80

ICPC

Cardiac arrhythmia NOS

1.4

11.7

485

3475

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

11.7

229

1395

U72

ICPC

Urethritis

1.9

11.7

135

703

EBA10, ,

SPAT

3.0

11.7

167

R03BA02

ATC

budesonide; inhalant

1.3

11.7

995

7957

W48

ICPC

Pregnancy, Clarification/discussion RFE/demand

4.5

11.6

N01

ICD-10 Finland

Rapidly progressive nephritic syndrome

30.0

11.6

T99

ICPC

Endocr/metab/nutrit disease other

2.2

11.6

100

468

R03DC03

ATC

montelukast; oral

1.3

11.6

931

7388

W92

ICPC

Compl labour/ delivery livebirth

2.1

11.6

101

475

X57

ICD-10 Finland

Unspecified privation

1.9

11.5

133

693

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

11.5

1081

8751

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

11.5

122

617

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

11.5

982

7856

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

11.5

578

4283

D60

ICPC

Digestive, Result test/procedure

8.6

11.5

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

3.3

11.4

128

EBA00

NOMESCO Finland

Extraction of tooth

1.2

11.4

2257

19784

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

2.8

11.4

208

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

11.3

2460

21743

R74

ICD-10 Finland

Abnormal serum enzyme levels

3.7

11.3

VALMI, ,

NOMESCO Finland

0.8

11.3

964

11907

P74

ICD-10 Finland

Other transitory neonatal electrolyte and metabolic disturbances

35.0

11.2

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

11.1

142

765

R4190

NOMESCO Finland

Nutritional therapy

1.6

11.1

257

1633

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

11.1

394

2746

WX320

NOMESCO Finland

Spinalanesthesy

1.2

11.1

1390

11633

S22.3

ICD-10 Finland

Fracture of rib

1.4

11.1

409

2872

IBA03

NOMESCO Finland

Psychotherapy evaluation

2.6

11.0

240

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

5.2

11.0

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.0

2837

25447

R03BA01

ATC

beclometasone; inhalant

1.3

11.0

740

5732

U05

ICPC

Urination problems other

1.5

11.0

296

1949

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.2

10.9

427

R11

ICD-10 Finland

Nausea and vomiting

1.4

10.9

496

3613

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.2

10.9

395

G83.4

ICD-10 Finland

Cauda equina syndrome

3.8

10.9

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

10.9

573

4277

H92.0

ICD-10 Finland

Otalgia

1.5

10.9

373

2582

H02AB06

ATC

prednisolone; systemic

1.2

10.8

2850

25594

ZXD05

NOMESCO Finland

Urgent procedure

1.2

10.8

1713

14681

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

10.8

211

1286

EBA30, ,

SPAT

3.4

10.8

108

W19

ICD-10 Finland

Unspecified fall

1.4

10.7

553

4113

ECB00, ,

SPAT

10.5

10.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.9

10.7

123

640

M48.0

ICD-10 Finland

Spinal stenosis

1.3

10.7

642

4888

D07AC01

ATC

betamethasone; topical

1.2

10.7

2149

18837

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.4

10.7

535

3960

R52.2

ICD-10 Finland

Other chronic pain

1.7

10.7

211

1290

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.1

10.7

431

S80.0

ICD-10 Finland

Contusion of knee

1.4

10.7

430

3067

C10AA07

ATC

rosuvastatin; oral

1.2

10.6

1971

17147

207

Kela drug reimbursment

Chronic arrhythmias

1.3

10.6

819

6462

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

10.6

414

2936

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

10.6

457

3302

P29

ICPC

Psychological sympt/compl other

1.4

10.5

427

3049

WZC00, ,

SPAT

1.3

10.5

877

6989

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.6

10.5

243

1546

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

9.1

10.5

C10AX09

ATC

ezetimibe; oral

1.3

10.5

968

7817

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

10.5

254

1634

U01, ,

ICD-10 Finland

110.1

10.4

G04CA02

ATC

tamsulosin; oral

1.2

10.4

1259

10487

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.5

10.4

124

2244

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

10.4

135

733

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

10.4

743

5805

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

10.3

1732

14916

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

10.3

437

3148

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

10.3

298

1994

TNH11, ,

SPAT

18.8

10.2

H13

ICD-10 Finland

Disorders of conjunctiva in diseases classified elsewhere

23.4

10.2

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

10.2

701

5446

-31

ICPC

Medical examin/health eval partial

0.6

10.1

141

2445

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

10.1

348

2410

H02AB07

ATC

prednisone; oral

1.3

10.1

694

5390

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.9

10.1

131

711

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

10.1

234

1490

N03AX09

ATC

lamotrigine; oral

1.5

10.0

262

1714

T43

ICPC

Metabolic, Other diagnostic procedure

10.0

U29

ICPC

Urinary symptom/complaint other

1.7

10.0

170

1000

H02

ICPC

Hearing complaint

1.3

10.0

809

6424

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.8

10.0

1875

21354

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

10.0

200

1229

P74

ICPC

Anxiety disorder/anxiety state

1.6

10.0

254

1653

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.2

9.9

346

RS222, ,

NOMESCO Finland

2.3

9.9

302

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

9.9

290

1945

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.5

9.9

259

1696

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

9.8

319

2185

W60

ICPC

Pregnancy, Result test/procedure

3.9

9.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

9.8

1584

13586

J01DA06

ATC

[U] cefuroxime

1.3

9.8

749

5903

TLC02, ,

SPAT

2.2

9.8

355

R50

ICD-10 Finland

Fever of other and unknown origin

3.5

9.7

ZXC20

NOMESCO Finland

Use of chemical agents

2.0

9.7

468

SGA01

NOMESCO Finland

Emergency treatment

1.3

9.7

928

7521

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

9.7

1641

14135

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

9.7

348

2432

ZYC01

NOMESCO Finland

Remote contact by phone

1.4

9.7

351

2457

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

9.7

1043

8572

F01

ICPC

Eye pain

1.7

9.7

168

994

L11

ICPC

Wrist symptom/complaint

1.4

9.7

523

3921

J02AC01

ATC

fluconazole; systemic

1.2

9.6

2166

19143

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.5

9.6

258

1699

R03AC03

ATC

terbutaline; inhalant

1.3

9.6

730

5748

X14

ICPC

Vaginal discharge

1.9

9.6

120

644

H02

ICD-10 Finland

Other disorders of eyelid

7.8

9.6

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

9.6

404

2907

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

9.5

475

3514

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

2.4

9.5

252

JDA05, ,

SPAT

11.3

9.5

A21.9

ICD-10 Finland

Tularaemia, unspecified

4.8

9.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

9.5

518

3890

N06AB06

ATC

sertraline; oral

1.3

9.5

622

4800

CS494

NOMESCO Finland

Other visual field testing

0.3

9.4

817

L14

ICPC

Leg/thigh symptom/complaint

1.4

9.4

450

3306

L95

ICPC

Osteoporosis

1.6

9.4

200

1247

U71, ,

ICD-10 Finland

100.1

9.4

N06AB03

ATC

fluoxetine; oral

1.3

9.4

640

4967

K03.66

ICD-10 Finland

Tooth plaque

1.4

9.4

465

3440

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

1.9

9.3

112

593

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.3

4265

39871

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

9.3

265

1768

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

9.3

3258

29828

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

9.3

1249

10514

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

9.2

244

1601

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

9.2

1779

15496

M20.2

ICD-10 Finland

Hallux rigidus

1.7

9.2

161

954

A02BC05

ATC

esomeprazole; systemic

1.2

9.2

2355

21016

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.8

9.2

984

11868

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

9.2

496

3717

IER01

NOMESCO Finland

Psychoeducation, group

2.6

9.2

197

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

9.2

1368

11630

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

9.2

405

2937

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

9.2

348

2457

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

9.2

444

3271

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.0

9.2

100

513

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.4

9.1

239

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

2.6

9.1

192

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

9.1

202

1273

N39

ICD-10 Finland

Other disorders of urinary system

2.6

9.1

204

S02

ICPC

Pruritus

1.6

9.1

198

1243

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

9.1

210

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

9.1

637

4962

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

9.0

368

2633

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

9.0

369

2642

G47.3

ICD-10 Finland

Sleep apnoea

1.2

9.0

1337

11361

H91.8

ICD-10 Finland

Other specified hearing loss

2.3

9.0

303

R50

ICPC

Respiratory, Medication/prescr/renewal

4.1

9.0

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

8.9

1960

17264

E10

ICD-10 Finland

Type 1 diabetes mellitus

1.9

8.9

105

553

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

8.9

689

5437

A01

ICD-10 Finland

Typhoid and paratyphoid fevers

24.0

8.9

B01AF02

ATC

apixaban; oral

1.3

8.9

710

5625

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

8.9

740

5894

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

8.9

509

3851

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

8.8

601

4662

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.4

8.8

478

3587

W90

ICPC

Uncompl labour/delivery livebirth

1.6

8.8

206

1317

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.7

823

6654

TNX10, ,

SPAT

2.5

8.7

208

K96

ICPC

Haemorrhoids

1.7

8.7

163

984

M01AH01

ATC

celecoxib; oral

1.3

8.7

924

7573

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.3

8.7

257

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

8.6

2203

19635

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

8.6

1473

12683

N30.0

ICD-10 Finland

Acute cystitis

1.2

8.6

929

7636

C10AA05

ATC

atorvastatin; oral

1.2

8.6

2423

21774

R06

ICPC

Nose bleed/epistaxis

1.8

8.5

130

742

N06AX16

ATC

venlafaxine; oral

1.3

8.5

766

6158

P58

ICPC

Psychological, Therapeutic counselling/listening

1.9

8.5

109

590

R07.0

ICD-10 Finland

Pain in throat

1.4

8.5

401

2943

S18

ICPC

Laceration/cut

1.2

8.5

2859

26035

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

8.5

1376

11788

T07

ICPC

Weight gain

2.0

8.4

459

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.2

8.4

325

SPAT1216

SPAT

Assessment of functional ability

1.3

8.4

775

6253

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

8.4

282

4006

J46

ICD-10 Finland

Status asthmaticus

1.7

8.4

145

859

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

8.4

1219

10334

A03

ICD-10 Finland

Shigellosis

12.7

8.4

M01AC06

ATC

meloxicam; systemic, rectal

1.2

8.3

2008

17802

T91

ICPC

Vitamin/nutritional deficiency

2.4

8.3

225

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

8.3

475

3590

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

8.3

393

2884

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

8.3

1042

8700

S01

ICPC

Pain/tenderness of skin

1.5

8.3

257

1747

R52.0

ICD-10 Finland

Acute pain

1.6

8.3

181

1139

B01AA03

ATC

warfarin; systemic

1.2

8.3

908

7473

A92

ICPC

Allergy/allergic reaction NOS

1.6

8.2

174

1085

K01

ICPC

Heart pain

2.2

8.2

315

R55

ICD-10 Finland

Syncope and collapse

1.3

8.2

572

4450

ZXY60

NOMESCO Finland

2-person team, nurses

3.1

8.2

107

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.3

8.2

493

3756

P20

ICPC

Memory disturbance

1.3

8.2

694

5539

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

8.2

537

4143

JN4BD

NOMESCO Finland

Extensive body CT

1.3

8.2

524

4031

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.2

1988

17637

R01

ICPC

Pain respiratory system

1.9

8.1

486

-44

ICPC

Preventive immunization/medic

0.7

8.1

204

3065

SPAT1262

SPAT

Handing over of treatment supplies

0.8

8.1

613

7704

K22

ICPC

Risk factor cardiovascular disease

1.4

8.1

306

2162

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

3.5

8.1

R96

ICD-10 Finland

Other sudden death, cause unknown

17.2

8.1

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.2

8.1

279

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

8.0

253

1725

R23

ICPC

Voice symptom/complaint

1.8

8.0

123

704

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

1.9

8.0

100

538

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

8.0

293

2058

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.3

8.0

588

4610

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

3.0

8.0

109

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.0

1496

12980

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

7.9

682

5452

H26.9

ICD-10 Finland

Cataract, unspecified

1.9

7.9

455

F34.1

ICD-10 Finland

Dysthymia

1.6

7.9

186

1190

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

3.4

7.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

7.9

567

4430

Z01.7

ICD-10 Finland

Laboratory examination

1.2

7.9

957

7959

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

1.6

7.9

163

1012

RJ128, ,

NOMESCO Finland

4.4

7.9

K04.09

ICD-10 Finland

Pulpit UNS

1.5

7.9

245

1667

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

7.9

191

1232

N06AB10

ATC

escitalopram; oral

1.2

7.9

1117

9440

J05AB11

ATC

valaciclovir; oral

1.3

7.9

781

6353

L04AX03

ATC

methotrexate; systemic

1.3

7.9

507

3903

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

7.8

327

2352

C03CA01

ATC

furosemide; systemic

1.2

7.8

1507

13104

L01

ICPC

Neck symptom/complaint

1.2

7.8

916

7593

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

7.8

369

2712

F99

ICPC

Eye/adnexa disease other

2.6

7.7

161

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.8

7.7

117

668

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

7.7

410

3067

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.8

7.7

107

595

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.6

7.7

173

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

3.6

7.7

L86

ICPC

Back syndrome with radiating pain

1.4

7.7

331

2392

WYA02, ,

SPAT

15.0

7.7

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

1.8

7.7

108

603

ZXY58

NOMESCO Finland

2-person team, nurse-occupational therapist

6.3

7.7

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

7.7

1178

10030

RS210, ,

NOMESCO Finland

3.5

7.7

K05

ICPC

Irregular heartbeat other

1.6

7.6

167

1052

A68

ICPC

General and Unspecified, Other referral NEC

3.0

7.6

112

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.7

7.6

130

768

A11, ,

ICD-10 Finland

18.3

7.6

TNF11, ,

SPAT

18.3

7.6

H29, ,

ICD-10 Finland

18.3

7.6

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.2

7.6

293

Y77

ICD-10 Finland

Ophthalmic devices associated with adverse incidents

25.0

7.6

L62

ICPC

Musculoskeletal, Administrative procedure

11.8

7.6

R01AD58

ATC

fluticasone, combinations; nasal

1.2

7.6

1418

12295

T14.1

ICD-10 Finland

Open wound of unspecified body region

2.4

7.5

205

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

7.5

471

3611

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.6

7.5

182

1174

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

7.5

321

2319

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

3.4

7.5

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

7.4

389

2904

D25

ICPC

Abdominal distension

1.8

7.4

109

617

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.5

7.4

189

1233

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

7.4

545

4272

N06AX12

ATC

bupropion; oral

1.4

7.4

375

2786

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.9

7.4

481

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

3.1

7.4

L20.8

ICD-10 Finland

Other atopic dermatitis

2.1

7.4

323

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

7.4

1038

8764

OAB50, ,

SPAT

0.7

7.3

236

3379

A08

ICD-10 Finland

Viral and other specified intestinal infections

3.7

7.3

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.9

7.3

504

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.1

7.3

291

I20

ICD-10 Finland

Angina pectoris

2.0

7.3

392

OAA51, ,

SPAT

2.8

7.3

126

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

2.8

7.3

126

A28

ICD-10 Finland

Other zoonotic bacterial diseases, not elsewhere classified

10.8

7.3

J01MA14

ATC

moxifloxacin; systemic

1.3

7.3

454

3480

C09CA06

ATC

candesartan; oral

1.2

7.3

1328

11486

XF612

NOMESCO Finland

Measurement of central venous pressure

4.1

7.3

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

3.5

7.2

Z3232

NOMESCO Finland

Midwife

1.4

7.2

321

2334

AN1

Coronary angiography

1.3

7.2

519

4057

M01AX17

ATC

nimesulide; oral

1.2

7.2

1217

10453

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

7.2

160

1013

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.2

702

5702

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

2.2

7.2

248

L95

ICD-10 Finland

Vasculitis limited to skin, not elsewhere classified

30.0

7.1

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

1.6

7.1

138

844

K85

ICD-10 Finland

Acute pancreatitis

2.0

7.1

382

EB1CA, ,

SPAT

2.3

7.1

211

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

7.1

287

2054

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

7.1

457

3519

RS220, ,

NOMESCO Finland

2.0

7.1

362

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.6

7.1

159

1009

R08

ICPC

Nose symptom/complaint other

1.5

7.1

188

1240

G54.0

ICD-10 Finland

Brachial plexus disorders

1.7

7.0

129

778

S97

ICPC

Chronic ulcer skin

1.4

7.0

314

2286

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

7.0

576

4579

ZX090

NOMESCO Finland

Other technic of radiotherapy

1.7

7.0

130

786

K04.08

ICD-10 Finland

Other specified pulpit

1.3

7.0

417

3174

K05.30

ICD-10 Finland

Periodontitis complex

1.2

7.0

824

6827

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.4

7.0

254

1783

L60.0

ICD-10 Finland

Ingrowing nail

1.4

7.0

254

1783

H10

ICD-10 Finland

Conjunctivitis

1.3

7.0

399

3021

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

7.0

994

8400

S24

ICPC

Hair/scalp symptom/complaint other

2.1

6.9

297

N06AX03

ATC

mianserin; oral

1.5

6.9

224

1537

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.5

6.9

174

1133

OAA11, ,

SPAT

1.5

6.9

235

1629

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

1.9

6.9

428

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

6.9

323

2370

A06AD11

ATC

lactulose; oral

1.2

6.9

703

5735

TKC10, ,

SPAT

7.5

6.9

L88

ICD-10 Finland

Pyoderma gangrenosum

4.0

6.9

R96

ICPC

Asthma

1.3

6.8

524

4131

F02

ICPC

Red eye

1.5

6.8

237

1650

ACC51

NOMESCO Finland

Release of median nerve

1.3

6.8

378

2849

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

6.8

536

4241

X60

ICPC

Female Genital, Result test/procedure

4.1

6.8

R32

ICD-10 Finland

Unspecified urinary incontinence

1.6

6.8

138

855

SPAT1312

SPAT

General health counselling

0.8

6.8

1415

16077

R04.0

ICD-10 Finland

Epistaxis

1.3

6.8

377

2843

S20.2

ICD-10 Finland

Contusion of thorax

1.4

6.8

276

1979

R03BB04

ATC

tiotropium bromide; inhalant

1.3

6.8

475

3702

J01FA15

ATC

telithromycin; oral

1.3

6.8

489

3826

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.5

6.8

183

1212

C08CA13

ATC

lercanidipine; oral

1.2

6.8

742

6104

H10.8

ICD-10 Finland

Other conjunctivitis

2.1

6.7

274

L05

ICD-10 Finland

Pilonidal cyst

6.1

6.7

D07AB08

ATC

desonide; topical

1.3

6.7

563

4486

D07AA02

ATC

hydrocortisone; topical

1.2

6.7

747

6150

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

6.7

373

2810

N17.8

ICD-10 Finland

Other acute renal failure

2.0

6.7

348

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

1.5

6.7

230

1597

A07AA02

ATC

nystatin; oral

1.4

6.7

277

1990

K03.19

ICD-10 Finland

Abrasion of the teeth UNS

1.8

6.7

475

R10

ICD-10 Finland

Abdominal and pelvic pain

1.9

6.7

404

R10.0

ICD-10 Finland

Acute abdomen

1.5

6.7

169

1102

D06

ICD-10 Finland

Carcinoma in situ of cervix uteri

7.1

6.7

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.2

6.7

687

5611

R51

ICD-10 Finland

Headache

1.4

6.7

291

2111

H03

ICD-10 Finland

Disorders of eyelid in diseases classified elsewhere

22.5

6.7

-, ,

ICD-10 Finland

1.8

6.7

102

586

S04

ICPC

Lump/swelling localized

1.3

6.7

603

4853

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.3

6.7

396

3016

L30.8

ICD-10 Finland

Other specified dermatitis

1.6

6.7

146

922

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.3

6.7

359

2695

Y29

ICPC

Genital symptom/complaint male other

2.4

6.6

174

N06AX05

ATC

trazodone; oral

1.7

6.6

122

737

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

6.6

642

5207

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

1.7

6.6

102

587

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

6.6

296

2157

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.4

6.6

287

2081

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.3

6.6

420

3230

M75.5

ICD-10 Finland

Bursitis of shoulder

1.7

6.6

123

746

LX1XE, ,

SPAT

5.9

6.6

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

6.6

559

4464

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

6.6

691

5656

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.7

6.6

125

762

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

6.6

351

2631

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

2.2

6.6

251

I20.09

ICD-10 Finland

Unstable angina

1.4

6.5

256

1823

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.8

6.5

523

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

6.5

294

2145

SPAT1334

SPAT

No further measures

2.3

6.5

188

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.5

1110

9537

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

1.9

6.5

395

A07EC01

ATC

sulfasalazine; oral, rectal

1.3

6.5

390

2976

K80.8

ICD-10 Finland

Other cholelithiasis

1.8

6.5

474

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.4

6.5

230

1610

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

6.5

506

4001

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.2

6.4

776

6448

D02

ICD-10 Finland

Carcinoma in situ of middle ear and respiratory system

69.9

6.4

S06.0

ICD-10 Finland

Concussion

1.3

6.4

574

4613

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.6

6.4

122

744

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

6.4

297

2177

LCA98

NOMESCO Finland

Other transluminal endoscopic operation on uterus

2.7

6.4

118

N06AX26

ATC

vortioxetine; oral

1.3

6.4

398

3051

Z32

ICD-10 Finland

Pregnancy examination and test

2.4

6.4

165

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

6.4

587

4734

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

6.4

557

R80

ICD-10 Finland

Isolated proteinuria

2.3

6.4

209

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

6.4

208

1433

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.3

6.4

444

3459

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

6.3

100

580

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

6.3

455

3558

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.3

826

6918

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

3.0

6.3

G03DB01

ATC

dydrogesterone; oral

1.3

6.3

545

4362

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.8

6.3

529

SPAT1215

SPAT

Assessment of need for medical rehabilitation

0.6

6.3

1413

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.2

6.3

822

6885

D01

ICD-10 Finland

Carcinoma in situ of other and unspecified digestive organs

11.0

6.3

QBA10, ,

SPAT

5.9

6.3

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.4

6.3

216

1503

DAX08

NOMESCO Finland

Fitting of hearing aid

0.6

6.2

131

2041

S12

ICPC

Insect bite/sting

1.3

6.2

446

3486

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

6.2

1269

11066

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.7

6.2

561

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

1.8

6.2

502

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

6.2

236

1673

KMAK, ,

NOMESCO Finland

0.9

6.2

2588

28021

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

6.2

571

4606

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

2.6

6.2

132

WX212

NOMESCO Finland

Femoral plexus blockade

1.7

6.2

116

706

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.5

6.2

199

1368

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.2

485

3838

E66.8

ICD-10 Finland

Other obesity

1.4

6.1

281

2056

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.5

6.1

177

1189

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

6.1

484

3831

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.4

6.1

294

2168

S23.4

ICD-10 Finland

Sprain and strain of ribs and sternum

1.8

6.1

475

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.6

6.1

125

777

K08.3

ICD-10 Finland

Retained dental root

1.3

6.1

408

3160

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

1.6

6.1

119

731

M62.6

ICD-10 Finland

Muscle strain

1.5

6.1

165

1094

S14

ICPC

Burn/scald

1.5

6.1

183

1240

MA3AE

NOMESCO Finland

Combined first trimester screening

1.4

6.1

220

1545

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.2

6.1

226

S19

ICPC

Skin injury other

1.5

6.1

201

1388

EB4VA, ,

NOMESCO Finland

0.8

6.1

689

8279

PA6AD

NOMESCO Finland

CT of neck arteries

1.5

6.1

189

1290

C07AA05

ATC

propranolol; systemic

1.2

6.1

1064

9159

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

6.1

990

11493

N30.8

ICD-10 Finland

Other cystitis

2.2

6.1

233

M05BA04

ATC

alendronic acid; oral

1.3

6.1

387

2979

N05CF02

ATC

zolpidem; oral

1.2

6.0

895

7587

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

6.0

443

3474

M15.8

ICD-10 Finland

Other polyarthrosis

1.7

6.0

102

604

WX290

NOMESCO Finland

Other blockage of nerve

1.1

6.0

2877

26640

SFA00

NOMESCO Finland

Small restoration

1.2

6.0

759

6336

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

575

641

9.66

307.65

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

990

987

11.47

307.65

1.3

1.1

3.27

0.65

6.43

(3011397) Hemoglobin [Presence] in Urine by Test strip

2897

15843

2.39

262.67

4.0

3.8

0.17

0.43

—

165

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2162

11672

2.22

189.28

3.5

3.0

1.06

1.09

e6/l

0.09

753

6270

(3018095) Leukocytes [#/volume] in Urine

3703

24520

2.05

188.24

5.1

4.1

54.52

93.05

e6/l

3.88

2326

17286

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2007

10695

2.22

180.02

3.6

3.2

2.60

2.49

e6/l

0.15

583

5268

(3015736) pH of Urine

3940

27525

1.95

162.63

3.8

3.5

6.29

6.22

2.27

1724

15526

(36304419) Bacteria [Presence] in Urine

2839

17762

1.99

162.01

3.9

3.3

0.00

216.41

estimate

—

(3002582) Erythrocytes [#/volume] in Urine

3258

21486

1.94

158.20

4.0

3.5

75.07

74.99

e6/l

0.00

2246

16436

(3030467) Casts [#/volume] in Urine by Automated count

2917

18639

1.95

154.59

4.0

3.4

0.44

0.40

e6/l

0.38

1893

13718

(3009261) Glucose [Presence] in Urine by Test strip

4599

34752

1.90

139.71

4.2

3.9

0.02

0.20

estimate

0.64

633

6911

(3035350) Ketones [Presence] in Urine by Test strip

4575

34526

1.89

139.38

4.2

3.9

10.55

4.45

estimate

0.69

684

7325

(3021601) Nitrite [Presence] in Urine by Test strip

4519

34172

1.87

134.39

4.2

3.9

0.00

estimate

0.27

670

7173

(3014051) Protein [Presence] in Urine by Test strip

2834

18732

1.85

128.81

3.1

2.9

0.31

0.06

0.63

429

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6215

52890

2.30

125.86

26.7

20.5

332.27

332.67

g/l

2.92

6201

52610

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1416

7639

2.06

116.19

1.9

—

(3018418) pH of Serum or Plasma

2858

19378

1.79

116.05

4.5

4.4

7.40

4.37

1635

13939

(3023368) Bacteria identified in Blood by Culture

2657

17859

1.77

109.46

4.9

4.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5159

41897

1.82

108.04

5.2

4.7

1749.21

1764.79

e6/l

0.00

555

(3033658) Prothrombin time (PT) actual/Normal

2529

16844

1.77

106.92

5.0

4.5

87.68

89.37

2.76

2493

16498

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6112

52530

2.10

106.78

24.4

19.9

13.63

13.59

1.95

6065

51867

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1214

6425

2.07

103.80

2.9

2.5

78.63

39.38

u/l

0.50

1057

5453

(3000991) Gas panel - Venous blood

1155

6122

2.06

97.86

9.7

9.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1402

8150

1.89

90.12

1.9

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4641

37434

1.68

89.81

10.5

10.1

4.21

4.12

e9/l

1.68

3679

32448

(3044889) 12 lead EKG panel

5221

43711

1.71

85.03

4.2

4.0

0.17

4682.61

0.68

(3014576) Chloride [Moles/volume] in Serum or Plasma

1500

9170

1.80

80.99

8.4

7.6

104.20

104.41

mmol/l

0.93

1500

9165

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

254

7493

0.31

77.56

4.7

4.9

30.91

32.25

1.23

174

5056

(3014111) Lactate [Moles/volume] in Serum or Plasma

1089

6104

1.92

77.09

8.3

8.4

1.37

1.33

mmol/l

0.60

1083

5988

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6756

62198

2.46

71.90

20.2

16.3

28.33

24.14

mg/l

19.35

5892

51259

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1195

7063

1.83

71.15

4.3

4.7

5.74

5.82

kpa

2.18

1172

6891

(3019150) Specific gravity of Urine by Refractometry

2174

15205

1.62

69.40

4.3

4.0

1.02

1.21

kg/l

0.77

1305

10207

(3019198) Lymphocytes [#/volume] in Blood

4222

34419

1.55

67.82

7.0

6.7

1.93

e9/l

0.02

3323

30324

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1855

12544

1.64

67.52

4.2

3.9

273.55

505.82

ng/l

1.53

1510

9700

(3002032) Base excess in Venous blood by calculation

1153

6899

1.80

65.41

4.3

4.7

1.46

1.75

mmol/l

1.97

1032

6006

(3012544) pH of Venous blood

1186

7175

1.78

64.76

4.2

4.7

7.37

7.38

0.39

572

4207

(3000850) Epithelial cells [#/volume] in Urine

2108

14878

1.59

63.63

2.8

6.47

5.47

e6/l

1.91

1948

13578

(3001604) Monocytes [#/volume] in Blood

4115

33668

1.52

62.54

7.0

6.7

0.58

0.59

e9/l

1.27

3153

28915

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3660

29233

1.51

62.30

7.7

7.2

1.20

1.21

mmol/l

18.07

3543

27164

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4119

33758

1.51

61.71

6.8

6.9

11.82

11.88

umol/l

0.10

3993

32186

(3006315) Basophils [#/volume] in Blood

4118

33756

1.51

61.58

7.0

6.7

0.04

e9/l

0.23

3158

28997

(3019550) Sodium [Moles/volume] in Serum or Plasma

6765

62955

2.29

59.10

22.9

19.0

139.41

139.66

mmol/l

12.97

6709

61791

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1627

10953

1.63

59.04

1.9

—

(3013115) Eosinophils [#/volume] in Blood

4203

34764

1.50

58.93

7.3

6.9

0.19

e9/l

0.09

3276

30399

(3023103) Potassium [Moles/volume] in Serum or Plasma

6773

63094

2.29

58.44

23.2

19.1

3.95

3.97

mmol/l

7.10

6712

61814

(3021589) Normoblasts [#/volume] in Blood

3634

29225

1.49

58.18

10.9

11.9

0.00

e9/l

1.84

2510

23828

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5526

48634

1.59

56.75

9.0

8.5

77.74

79.77

u/l

2.93

5367

46274

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

645

3423

1.97

52.55

2.9

3.5

0.57

0.62

4.33

645

3406

(3024354) Oxygen [Partial pressure] in Venous blood

975

5942

1.74

50.89

3.5

4.2

4.54

4.64

kpa

0.77

949

5787

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3933

32612

1.45

50.78

8.0

7.8

1.20

1.21

mmol/l

10.34

3657

28294

(3019977) pH of Arterial blood

1185

7726

1.64

47.71

9.1

8.1

7.42

1.78

558

4222

(3003396) Base excess in Arterial blood by calculation

1177

7678

1.64

47.24

9.1

8.0

0.56

0.93

mmol/l

2.75

1007

6300

(3024928) Oxygen saturation in Venous blood

382

1729

2.28

47.14

2.7

4.2

59.05

62.54

2.29

373

1687

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4694

40544

1.45

46.77

3.3

3.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1019

6432

1.68

46.43

9.9

8.9

122.05

121.75

g/l

0.17

1003

6285

(3027801) Oxygen [Partial pressure] in Arterial blood

1179

7729

1.63

46.30

9.2

8.1

12.41

12.45

kpa

0.08

1147

7446

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1178

7730

1.63

46.05

9.2

8.1

5.02

5.10

kpa

2.84

1146

7451

(3024561) Albumin [Mass/volume] in Serum or Plasma

3528

29002

1.42

45.62

5.5

5.4

35.90

35.77

g/l

0.73

3398

27256

(3019225) pH of Specimen

257

5980

0.41

45.15

4.4

4.3

7.28

7.35

2.27

199

4320

(3016502) Oxygen saturation in Arterial blood

1065

6898

1.64

43.68

9.5

8.4

95.72

95.54

0.42

1035

6664

(3013826) Glucose [Moles/volume] in Serum or Plasma

4448

38260

1.43

43.66

6.2

5.3

6.64

6.67

mmol/l

0.43

4305

36175

(3007461) Platelets [#/volume] in Blood

7045

67673

3.21

42.01

29.3

24.6

245.32

251.48

e9/l

11.72

6774

66422

(3000963) Hemoglobin [Mass/volume] in Blood

7046

67711

3.20

41.53

29.5

24.8

134.93

135.60

g/l

3.48

7027

67092

(3026782) Osmolality of Urine

1736

12670

1.49

41.52

2.9

3.0

537.35

535.39

mosm/kgh2o

0.13

1535

11160

(3026361) Erythrocytes [#/volume] in Blood

7045

67697

3.19

41.51

29.2

24.6

4.48

4.51

e12/l

5.82

6759

66243

(3035941) MCH [Entitic mass]

7044

67688

3.17

41.39

29.2

24.5

30.34

30.29

1.58

7024

67057

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7044

67690

3.17

41.35

29.2

24.5

91.06

90.89

2.62

7022

67059

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7044

67695

3.16

41.25

30.2

25.1

41.51

40.84

0.38

7021

67031

(3010813) Leukocytes [#/volume] in Blood

7044

67705

3.16

41.04

29.3

24.6

6.93

6.76

e9/l

5.40

6751

66241

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6907

65796

2.31

40.76

24.9

20.7

77.90

77.20

umol/l

0.90

6871

65075

(3002030) Lymphocytes/Leukocytes in Blood

3783

31847

1.40

40.61

7.1

6.9

27.61

28.04

1.51

3666

30227

(3004119) Hemoglobin [Mass/volume] in Venous blood

701

4143

1.77

40.23

3.0

3.9

131.15

129.60

g/l

1.04

692

4018

(3013512) EKG study

1619

21607

0.68

40.22

3.2

3.6

0.67

0.75

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6363

59113

1.67

40.17

19.2

15.6

82.56

82.38

ml/min/173m2

0.28

5669

54529

(3018010) Neutrophils/Leukocytes in Blood

3718

31267

1.39

39.83

7.0

6.8

57.08

57.02

0.11

3632

29923

(3026008) Bacteria identified in Urine by Culture

2445

19154

1.42

39.75

3.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

300

1325

2.32

39.18

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

300

1325

2.32

39.18

1.3

—

(3019069) Monocytes/Leukocytes in Blood

3691

31093

1.38

38.62

7.2

7.0

8.85

0.04

3563

29212

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1694

12465

1.47

38.38

3.0

3.1

2.45

mmol/l

0.94

1567

11150

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

678

4037

1.75

37.82

11.2

10.1

24.19

24.28

mmol/l

0.29

667

3967

(3006504) Eosinophils/Leukocytes in Blood

3671

31030

1.37

36.88

7.1

6.9

2.83

2.86

0.27

3553

29139

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6856

65361

2.08

36.41

13.5

12.3

26.88

26.68

u/l

0.31

6790

63618

(3022096) Basophils/Leukocytes in Blood

3661

31001

1.37

35.99

7.2

7.0

0.67

0.68

0.12

3536

29086

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1132

7815

1.53

34.59

3.0

3.1

6.75

8.26

umol/l

2.43

1024

6846

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

655

3989

1.71

33.54

1.8

1.7

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5225

47120

1.40

33.12

4.7

4.4

12.11

11.69

mm/h

1.38

5063

44260

(3020779) Urea [Moles/volume] in Serum or Plasma

935

6269

1.56

32.44

6.9

8.5

10.19

9.59

mmol/l

1.64

911

6025

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

629

3877

1.68

30.70

10.1

10.7

16.24

16.03

0.95

612

3740

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3346

28356

1.34

30.68

2.2

2.1

94.86

95.91

pmol/l

0.67

1724

15241

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6187

57863

1.50

29.41

5.4

5.3

1.87

1.89

mu/l

0.59

5974

53874

(40758558) Short blood count panel - Blood

2453

19949

1.35

29.30

6.7

6.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1397

10374

1.43

28.97

2.1

2.4

29.69

29.72

0.06

1376

10091

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

352

1862

1.93

28.65

2.6

2.3

0.00

g/l

0.38

315

1642

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

330

1737

1.94

27.25

2.6

2.3

0.00

g/l

-0.00

315

1640

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2663

22199

1.32

25.91

3.6

3.4

30.64

34.87

u/l

3.30

2584

20965

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6500

61729

1.55

25.56

5.7

2.65

2.70

mmol/l

5.74

6300

57819

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

352

1943

1.85

25.13

2.5

2.2

0.01

0.02

g/l

1.52

326

1758

(3052851) Hemolysis interference index of Serum or Plasma

333

1807

1.88

25.08

3.2

3.3

2.37

2.17

index

0.16

130

966

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1830

14530

1.35

24.70

1.8

1.9

1.21

1.26

mg/l

0.27

1466

11256

(3007853) Bacteria identified in Skin by Aerobe culture

1083

7894

1.44

24.45

1.9

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

729

4911

1.54

24.39

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5337

49081

1.34

24.32

4.4

14.72

14.74

pmol/l

0.17

5110

45321

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

715

4800

1.54

24.30

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

554

3511

1.63

24.10

1.1

64.84

1.97

u/ml

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2635

22107

1.30

23.89

4.1

3.6

2.36

2.35

mmol/l

1.52

2514

20163

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2408

20006

1.31

23.34

2.2

2.3

248.39

218.03

u/l

0.54

2321

18952

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6251

59079

1.44

23.24

4.8

5.1

5.98

5.92

mmol/l

2.94

6023

54623

(3020891) Body temperature

490

3041

1.65

23.16

5.1

4.6

36.95

36.92

°c

0.96

485

3014

(3028707) Methadone [Presence] in Urine by Screen method

237

1201

2.01

21.87

3.0

2.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2211

18351

1.29

21.05

1.8

1.7

20.32

19.99

nmol/l

0.50

2004

15683

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

378

2267

1.70

20.33

2.6

2.3

10.14

10.20

g/l

0.12

355

2038

(4094501) Cardiovascular stress test using bicycle ergometer

313

1798

1.77

19.62

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1510

11994

1.33

19.60

1.4

1.3

36.51

30.11

iu/ml

0.73

406

3556

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

143

630

2.29

18.94

4.0

3.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

374

2284

1.67

18.79

2.8

2.4

0.75

0.86

g/l

0.23

341

1976

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

392

2.65

18.69

1.5

3.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

368

2242

1.67

18.66

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1205

9351

1.35

18.18

1.4

429.41

514.29

titre

0.91

204

1961

(3022948) Iron [Moles/volume] in Serum or Plasma

1440

11477

1.32

18.05

2.8

2.7

12.91

13.15

umol/l

0.63

1386

10754

(1761868) Lipid panel - Serum or Plasma

2108

24764

0.79

17.78

2.9

3.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

437

2845

1.57

16.92

1.5

1.6

20.12

15.07

iu/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1948

16272

1.27

16.80

2.4

2.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3518

31403

1.23

16.71

3.4

3.2

119.20

123.22

ug/l

0.46

3422

29443

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6104

58052

1.34

16.70

6.2

6.3

39.34

39.10

mmol/mol

1.33

5927

54610

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

463

3068

1.54

16.57

1.7

1.8

1.46

1.52

g/l

0.71

420

2654

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6366

60959

1.39

16.50

4.9

5.1

4.52

4.61

mmol/l

10.07

6168

57339

(3032080) INR in Blood by Coagulation assay

3312

29410

1.23

16.41

17.6

14.8

1.28

1.25

inr

3.10

2673

24591

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2199

18674

1.25

16.40

3.1

3.3

1241.62

1321.43

ng/l

0.43

1975

16062

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1252

9908

1.32

16.33

2.9

2.8

22.01

22.70

1.08

1209

9253

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

385

2486

1.58

15.45

2.7

2.3

3.07

2.89

g/l

3.49

362

2279

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

487

3315

1.50

15.37

1.4

1.5

—

(3022313) Gas panel - Capillary blood

194

3457

0.55

15.30

4.6

5.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

720

5286

1.40

15.20

2.4

2.3

7.01

7.45

ug/l

0.22

664

4687

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

2646

1.55

15.04

2.7

2.3

3.78

3.71

g/l

0.32

380

2438

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

2649

1.55

14.96

2.7

2.3

7.29

7.37

g/l

0.40

380

2439

(3024891) Influenza virus A+B Ag [Presence] in Specimen

295

1804

1.66

14.79

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

402

2648

1.55

14.79

2.7

2.3

4.11

4.22

g/l

2.76

379

2440

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2927

25843

1.22

14.75

4.2

3.8

0.07

0.22

estimate

0.59

566

5913

(1001926) Buprenorphine [Presence] in Urine by Screen method

345

2196

1.60

14.72

2.5

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3282

29332

1.22

14.60

2.6

2.5

76.13

76.65

nmol/l

0.53

3138

26740

(3044640) Blood type and Crossmatch panel - Blood

2454

21300

1.23

14.55

2.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1326

10752

1.29

14.20

2.9

2.7

2.30

2.33

g/l

1.66

1278

9989

(3023420) DNA double strand Ab [Units/volume] in Serum

410

2744

1.52

14.03

1.9

1.8

8.44

6.84

iu/ml

0.35

664

(3016879) Cocaine [Presence] in Urine

391

2600

1.53

13.79

2.4

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2035

17403

1.24

13.70

2.3

2.4

2.54

2.77

mg/l

4.47

1808

15153

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1128

9001

1.30

13.62

6.7

6.9

1.07

1.06

mmol/l

0.67

1077

8430

(3042936) Bacteria identified in Isolate by Culture

1180

9474

1.29

13.59

2.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

275

1690

1.65

13.55

1.3

—

(3027944) Amphetamines [Presence] in Urine

409

2760

1.51

13.46

2.4

2.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

159

838

1.92

13.25

1.7

1.5

—

(36660697) Celiac disease serology panel - Serum

745

5623

1.36

13.23

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1368

11224

1.27

13.21

3.6

3.9

0.81

0.82

mmol/l

2.81

1306

10596

(3008152) Bicarbonate [Moles/volume] in Arterial blood

561

4041

1.42

13.18

7.8

6.9

24.35

24.51

mmol/l

0.48

540

3866

(4198724) Urine methamphetamine measurement

310

2.53

13.09

1.8

3.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

303

1925

1.60

13.06

3.9

3.3

1.46

2.82

ratio

3.12

134

1110

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

323

2087

1.57

12.96

1.8

1.7

0.23

g/l

0.09

309

1982

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6303

60618

1.32

12.92

4.7

5.0

1.41

1.45

mmol/l

8.38

6089

56673

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

117

2312

0.50

12.92

2.1

1.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

331

2154

1.56

12.88

1.8

1.7

1.19

g/l

0.10

315

2048

(3020630) Protein [Mass/volume] in Serum or Plasma

729

5518

1.36

12.69

2.9

2.7

65.78

66.38

g/l

1.30

694

5083

(3000764) Benzodiazepines [Presence] in Urine

408

2790

1.49

12.60

2.4

2.2

—

(3027008) Opiates [Presence] in Urine

409

2799

1.49

12.59

2.4

2.0

—

(3028300) Cannabinoids [Presence] in Urine

410

2809

1.49

12.55

2.4

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

907

7101

1.32

12.54

8.9

6.7

—

(3009508) Creatinine [Moles/volume] in Urine

2571

22681

1.21

12.40

3.6

7.61

7.69

mmol/l

0.42

2344

19343

(3018405) Lactate [Moles/volume] in Arterial blood

323

2109

1.56

12.39

5.1

3.8

1.32

1.39

mmol/l

0.66

318

2072

(46235355) HIV 1 and 2 tests - Meaningful Use set

1528

12784

1.25

12.37

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

1096

8820

1.29

12.30

2.3

2.5

125.03

131.40

ug/g

0.31

938

7087

(3034860) Kappa light chains.free [Mass/volume] in Serum

328

2156

1.55

12.22

4.2

3.4

45.81

77.28

mg/l

0.67

295

1840

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1345

11116

1.26

12.10

1.3

7.49

11.09

u/ml

1.57

504

4316

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

327

2154

1.54

12.07

4.2

3.4

38.24

53.92

mg/l

1.21

294

1836

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

975

7750

1.30

12.02

4.6

237.87

243.26

u/l

0.62

947

7374

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

288

1851

1.58

11.85

1.6

1.5

25.17

13.29

iu/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

209

1239

1.71

11.85

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

139

2518

0.54

11.64

2.4

2.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

666

5041

1.35

11.57

2.5

3.1

202.19

188.94

ng/l

0.34

620

4603

(3029937) Albumin [Presence] in Urine by Test strip

2159

18833

1.21

11.51

4.6

4.1

0.00

estimate

0.22

619

6623

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

350

2365

1.50

11.48

3.9

3.6

305.19

2513.77

u/ml

1.18

302

2051

(44816559) Phosphatidylethanol [Mass/volume] in Blood

418

2929

1.45

11.42

1.9

1.7

0.27

0.32

mg/l

1.56

217

1391

(3000475) Leukocytes [#/volume] in Synovial fluid

254

1613

1.59

11.02

1.6

12083.63

13003.34

e6/l

0.15

153

1135

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3349

30484

1.18

10.90

2.9

—

estimate

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

601

4520

1.36

10.88

2.5

2.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

159

2.97

10.78

1.3

1.1

257.14

588.57

titre

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

169

2828

0.59

10.62

4.7

5.4

24.33

24.69

mmol/l

1.20

158

2649

(3026493) Urate [Moles/volume] in Serum or Plasma

1983

17269

1.20

10.57

3.1

2.8

339.48

343.33

umol/l

0.96

1842

15366

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

679

5224

1.33

10.56

2.6

2.8

65.83

67.52

ml/min/173m2

0.54

276

2201

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

223

1397

1.61

10.27

1.7

1.6

—

(3027945) Reticulocytes/Erythrocytes in Blood

957

7737

1.27

10.24

2.8

2.9

1.81

1.77

0.41

916

6937

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2952

26711

1.18

10.01

1.9

1.41

1.37

mmol/l

1.62

2679

22624

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

219

1376

1.61

9.97

1.4

1.6

137.52

144.68

au/ml

0.40

398

(3021879) Hepatitis B virus core Ab [Presence] in Serum

681

5296

1.31

9.81

1.6

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

288

1940

1.50

9.64

3.8

3.0

—

(3009343) pH of Capillary blood

339

4776

0.69

9.60

4.0

4.9

7.42

7.41

0.08

284

3944

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

229

1472

1.57

9.49

1.3

1.4

236.94

266.59

u/ml

1.20

164

897

(3015171) Extractable nuclear Ab [Units/volume] in Serum

366

2596

1.43

9.40

1.3

1.2

0.29

1.02

u/ml

2.79

209

(44790047) Parainfluenza type 1 nucleic acid detection

157

920

1.72

9.37

1.5

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

157

920

1.72

9.37

1.5

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

157

920

1.72

9.37

1.5

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

157

920

1.72

9.37

1.5

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

375

2.14

9.33

1.2

33.57

23.32

u/l

0.71

311

(3036489) Thrombin time

374

2669

1.42

9.29

2.2

2.6

20.82

21.16

0.59

353

2369

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

233

1513

1.56

9.25

1.4

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

354

4902

0.71

9.08

3.9

4.8

4.99

5.14

kpa

3.35

341

4712

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

387

2.10

9.01

1.2

102.01

88.90

u/l

0.54

329

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

314

2192

1.45

8.81

2.6

3.2

3.88

3.50

g/l

4.30

306

2091

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

227

1484

1.55

8.76

1.2

43.21

42.81

u/ml

0.01

144

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

100

525

1.92

8.59

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

496

3758

1.34

8.57

2.4

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1919

16923

1.18

8.54

4.4

22.56

21.94

0.88

869

8120

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

105

570

1.85

8.16

1.2

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

511

1.89

7.94

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

360

2.07

7.91

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

360

2.07

7.91

1.3

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

755

0.33

7.89

1.6

2.1

18.82

23.87

mg/l

0.45

273

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

297

2098

1.43

7.86

2.5

3.1

188.76

190.66

0.15

287

2008

(40759836) Histone Ab [Presence] in Serum by Immunoblot

102

557

1.84

7.80

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

139

831

1.68

7.79

1.2

1.3

31.35

51.76

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1442

12494

1.19

7.77

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

740

5991

1.26

7.76

2.6

2.8

70.26

69.60

e9/l

0.13

406

4363

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

233

1580

1.49

7.63

1.2

1.4

51.26

66.05

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

327

2365

1.40

7.58

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

100

550

1.83

7.49

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

100

551

1.83

7.45

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

232

1581

1.48

7.42

1.4

1.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

220

2.33

7.35

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1577

13844

1.18

7.23

1.6

1.5

2.33

2.39

g/l

0.53

912

8599

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

316

2293

1.39

7.20

2.3

3.2

91.87

92.69

0.28

311

2216

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

528

4145

1.29

7.11

3.4

3.5

4.51

4.53

pmol/l

0.12

496

3724

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

311

4221

0.72

7.08

3.7

4.8

1.50

1.68

mmol/l

0.42

213

3148

(3017143) Hepatitis C virus Ab [Presence] in Serum

942

7913

1.22

7.02

1.8

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

324

2379

1.38

6.90

2.3

674.60

618.94

ug/l

0.09

313

2261

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

536

1.80

6.89

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1111

9508

1.20

6.80

1.5

—

(3012516) Albumin [Mass/volume] in Urine

2299

20851

1.15

6.79

3.6

3.5

66.03

49.80

mg/l

1.56

1623

13560

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

504

1.81

6.71

1.6

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

329

2436

1.37

6.66

1.2

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

247

1742

1.43

6.65

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

622

5027

1.26

6.63

4.3

4.4

94.45

89.93

ng/l

0.49

588

4362

(40768797) Stomach Pathology biopsy report

1054

9006

1.20

6.55

1.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

329

0.21

6.54

1.1

1.3

—

(3005033) Fetal Nuchal fold Thickness US

197

1337

1.49

6.48

1.4

1.5

1.26

0.00

147

962

(3047352) Trisomy 18 risk [Likelihood] in Fetus

199

1354

1.48

6.47

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

203

1388

1.47

6.44

1.4

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

556

4452

1.27

6.41

1.2

—

(3000494) Fungus identified in Specimen by Culture

955

8102

1.21

6.41

1.4

1.5

—

(3045788) Cell count panel - Pleural fluid

106

623

1.71

6.40

1.4

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

300

2204

1.38

6.39

3.1

3.9

0.30

0.34

iu/ml

1.47

148

1212

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

244

1735

1.42

6.30

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

471

1.81

6.29

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

637

1.69

6.18

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

226

1598

1.43

6.04

1.8

1.6

1467.66

3477.16

e6/l

0.39

168

1248

(3014765) Yersinia sp identified in Stool by Organism specific culture

244

1749

1.41

6.04

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

324

2439

1.34

5.93

1.6

1.7

—

(4146454) Self-monitoring of blood glucose

670

0.40

5.69

2.9

2.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2313

21184

1.13

5.67

4.1

4.2

12.10

9.70

mg/mmol

0.94

1562

13477

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

221

1576

1.41

5.65

1.8

1.6

26.33

25.60

e6/l

0.02

159

1148

(21494890) Protein electrophoresis panel - 24 hour Urine

106

646

1.65

5.64

2.1

—

(3045424) Erythrocytes [Presence] in Urine

239

3253

0.73

5.60

1.9

2.1

0.01

0.26

estimate

0.52

118

1043

(40760892) CBC W Ordered Manual Differential panel - Blood

1651

14801

1.15

5.56

5.2

4.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

242

1761

1.39

5.51

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

120

761

1.59

5.45

1.4

1.5

1241.81

3583.50

e6/l

1.30

544

(3016650) Hepatitis A virus Ab [Presence] in Serum

170

1167

1.47

5.36

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

197

1391

1.43

5.35

1.4

1.5

—

(3023410) Appearance of Cerebral spinal fluid

117

742

1.59

5.32

2.0

—

(3049717) Cytology report of Urine Cyto stain

305

2315

1.33

5.32

2.4

2.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

107

666

1.61

5.27

1.4

1.5

16333.20

66560.14

e6/l

2.74

381

(3000570) Elastase.pancreatic [Mass/mass] in Stool

275

2062

1.35

5.21

1.5

1.4

261.00

277.98

ug/g

0.66

165

1197

(3037756) Immunofixation for Serum or Plasma

186

1311

1.43

5.12

1.7

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

262

1956

1.35

5.11

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1731

15653

1.14

5.07

1.4

1.69

1.91

u/ml

0.25

435

4191

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

344

1.84

4.97

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2252

20730

1.12

4.93

2.9

2.7

69.01

63.54

u/l

0.22

2134

19273

(3004716) Salmonella sp identified in Stool by Organism specific culture

391

3110

1.27

4.83

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

544

4492

1.23

4.82

1.4

1.3

274.17

254.42

u/ml

0.12

518

4175

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

236

1753

1.36

4.79

2.2

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

247

1850

1.35

4.75

1.6

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

714

6063

1.20

4.74

2.7

2.3

12.68

13.14

nmol/l

0.76

656

5506

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

267

2025

1.33

4.72

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1407

12606

1.14

4.71

2.9

3.2

0.79

0.76

ug/l

0.31

961

8094

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1176

13218

0.87

4.69

1.6

1.7

12171811.42

31661704.03

pmol/l

1.20

1027

11124

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

556

1.63

4.62

1.3

1.4

86.20

81.31

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

220

1628

1.36

4.59

2.0

2.4

134.40

129.57

g/l

2.00

139

1271

(3014271) Vancomycin [Susceptibility]

282

0.28

4.48

3.3

2.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

633

1.57

4.42

1.3

1.4

6.50

6.33

mmol/l

0.31

593

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

107

698

1.54

4.38

1.3

1.40

1.54

nmol/l

0.68

632

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

209

1547

1.36

4.37

1.2

10.94

3.55

u/ml

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

235

1777

1.33

4.28

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

164

1171

1.41

4.27

1.1

—

(3022145) Colonoscopy Study observation

860

7486

1.17

4.27

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

365

2927

1.26

4.25

3.4

3.8

24.52

25.23

mmol/l

3.96

354

2822

(4034850) Laboratory test

246

1881

1.32

4.15

10.4

10.1

—

(3006245) CD3-CD19+ cells/cells in Blood

343

1.75

4.14

2.9

2.6

10.44

11.63

0.39

324

(4268621) Lupus anticoagulant assay

114

765

1.50

4.12

2.4

2.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.99

4.11

1.6

2.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

746

6440

1.18

4.11

2.3

2.4

383.54

374.20

nmol/l

0.55

703

5983

(3030981) Hyaline casts [#/volume] in Urine by Automated count

632

5380

1.19

4.10

2.4

2.6

0.66

0.43

e6/l

1.00

613

5158

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

216

0.23

4.07

1.2

1.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

130

2.23

3.97

1.2

0.89

136.04

mg/l

1.47

(3000060) B lymphocytes [#/volume] in Blood

269

1.83

3.88

2.9

2.5

0.20

0.36

e9/l

0.95

134

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

403

1.67

3.88

1.2

1.5

5.28

6.39

u/l

1.20

350

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

262

1.84

3.87

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

241

1.87

3.85

2.2

2.3

57.95

73.04

ug/l

0.67

234

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.77

3.84

1.8

1.6

2.83

0.87

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.77

3.84

1.8

1.6

2.70

2.63

mg/l

0.01

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.77

3.84

1.8

1.6

1.10

0.89

mg/l

0.11

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.77

3.84

1.8

1.6

0.94

2.01

mg/l

0.66

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.77

3.84

1.8

1.6

2.09

1.63

mg/l

0.14

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.77

3.84

1.8

1.6

1.69

1.71

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.77

3.84

1.8

1.6

4.24

3.96

mg/l

0.05

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

133

934

1.43

3.84

1.3

0.57

2.50

nmol/l

0.52

124

903

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

201

1512

1.34

3.83

1.7

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

752

6539

1.17

3.79

2.4

0.22

0.21

g/l

1.93

713

6116

(40761536) Microorganisms panel - Urine sediment

435

5216

0.82

3.79

4.3

4.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

1326

1.36

3.78

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

659

1.51

3.75

1.2

58.96

68.01

u/l

0.71

580

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.73

3.74

1.8

1.6

0.66

1.08

mg/l

0.47

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

152

1099

1.39

3.73

1.2

1.3

1.65

3.76

u/ml

3.77

389

(3025941) Bacteria identified in Stool by Culture

428

3546

1.22

3.73

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

255

1992

1.29

3.72

1.2

1.3

2.98

39.57

u/ml

—

110

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

557

1.55

3.70

1.1

1.2

146.67

167.62

titre

0.11

101

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

455

1.61

3.69

1.3

1.5

12.77

12.66

u/l

0.04

438

(3004616) Nuclear Ab [Presence] in Serum

813

0.57

3.61

1.2

1.3

—

(3012441) Differential panel - Pleural fluid

650

1.50

3.58

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

619

7150

0.85

3.54

1.9

3.52

ratio

0.02

468

5457

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

180

1350

1.34

3.53

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

397

3284

1.22

3.53

1.1

1.2

100.00

158.87

titre

—

106

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

279

1.76

3.48

3.8

3.6

1.39

1.25

0.24

279

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

199

1519

1.32

3.47

5.6

6.5

1095.88

1485.99

iu/ml

0.13

225

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

471

1.58

3.46

1.0

1.1

—

0.62

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

148

1082

1.37

3.43

1.3

2.99

4.35

u/ml

1.41

495

(4024509) Urine culture

238

3011

0.78

3.42

1.8

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

238

1866

1.28

3.40

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

133

958

1.39

3.37

5.1

5.6

345.42

365.47

umol/l

0.91

118

846

(3025468) Yersinia sp identified in Specimen by Organism specific culture

807

0.59

3.33

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5910

57830

1.12

3.33

4.0

4.3

1.33

1.29

mmol/l

2.98

5684

53582

(3006653) Thiamine [Moles/volume] in Blood

336

1.67

3.32

1.2

1.3

135.34

136.61

nmol/l

0.08

336

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

120

852

1.41

3.31

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

276

2214

1.26

3.28

2.4

2.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

815

0.60

3.27

1.6

1.4

—

(3035880) pH of Pleural fluid

338

1.66

3.26

1.2

1.4

7.49

7.40

2.08

238

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

133

965

1.38

3.25

1.3

0.23

0.27

nmol/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.34

3.23

1.8

2.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

812

0.60

3.23

1.6

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

450

5293

0.84

3.22

1.6

1.7

3.49

3.46

mmol/l

0.14

296

3610

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

237

1872

1.27

3.21

1.3

24.63

7.24

u/ml

0.88

267

(3006922) Hepatitis E virus Ab [Presence] in Serum

544

1.51

3.21

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

839

7446

1.14

3.21

1.6

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

503

4297

1.18

3.19

1.3

61.90

53.79

au/ml

0.29

282

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

115

818

1.41

3.16

1.2

1.3

0.16

0.21

nmol/l

1.16

661

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

236

1.78

3.15

2.8

0.60

0.61

mmol/l

0.32

236

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

540

4653

1.17

3.09

2.4

23.05

20.97

au/ml

0.23

506

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

445

1.55

3.09

1.3

11.09

12.63

u/l

0.41

406

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

398

1.59

3.08

1.2

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

161

1216

1.33

3.06

3.1

3.9

2105.00

1661.54

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

825

0.62

3.06

1.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

229

1815

1.27

3.04

1.8

1.5

524.75

533.94

mg/l

0.11

223

1729

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2253

21165

1.09

3.03

5.5

5.4

3.54

2.63

ug/l

0.45

2109

19287

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

569

1.48

3.00

1.2

1.4

10.80

8.74

mmol/l

2.99

544

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.55

2.98

1.2

1.3

41.83

34.11

—

(3047189) Immunofixation for 24 hour Urine

301

1.66

2.97

2.1

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

197

1.83

2.96

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

411

1.56

2.93

1.1

6.60

12.57

nmol/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

302

2481

1.23

2.93

1.8

1.7

311.60

294.67

mu/l

0.42

288

2256

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

234

1871

1.26

2.90

1.2

1.3

8.42

5.07

u/ml

0.23

168

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1187

10830

1.11

2.89

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

848

0.63

2.88

1.5

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

270

2198

1.24

2.86

1.4

1.5

17.88

4.00

iu/ml

0.52

400

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

560

0.55

2.86

1.2

—

72.82

—

(3038026) Centromere Ab [Units/volume] in Serum

479

0.52

2.80

1.1

1.2

—

44.16

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

464

1.51

2.80

1.2

4.99

3.14

u/ml

0.17

151

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

209

1.77

2.77

1.3

1.4

123.20

125.21

nmol/l

0.03

152

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

588

1.45

2.76

1.3

1.4

238.46

349.94

u/l

2.10

560

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

207

1643

1.27

2.75

1.4

1.5

0.95

1.17

ratio

2.03

993

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

221

1768

1.26

2.75

1.4

1.5

60.41

61.12

ug/l

0.04

179

1482

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

903

8135

1.12

2.75

1.9

1.8

1.52

1.47

1.20

831

7151

(3003434) Protein [Mass/volume] in Pleural fluid

118

867

1.37

2.73

1.4

1.5

32.07

32.72

g/l

0.23

104

783

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

205

1629

1.27

2.71

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

207

1647

1.26

2.70

1.4

1.5

1.06

1.21

ratio

0.91

1002

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

207

1647

1.26

2.70

1.4

1.5

0.98

0.94

ratio

0.14

997

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

234

1.71

2.67

1.2

1.3

0.30

g/l

0.05

189

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

844

0.65

2.66

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

2695

25621

1.08

2.66

2.2

2.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.93

2.61

1.7

3.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.93

2.61

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.46

2.61

1.5

1.3

0.21

0.54

iu/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

305

0.42

2.59

2.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

237

1.69

2.56

1.5

1.4

247.18

266.23

nmol/24h

0.03

237

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

320

2684

1.20

2.56

2.2

2.0

1.71

2.32

ug/l

0.64

296

2402

(40757494) Bilirubin.total [Moles/volume] in Blood

340

1.56

2.49

2.5

93.40

54.95

umol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

364

1.54

2.49

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

705

1.38

2.44

1.3

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.24

2.43

1.4

1.3

1.08

1.29

iu/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

173

1368

1.27

2.42

1.1

0.46

1.05

u/ml

2.55

646

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

335

1.56

2.41

1.5

2.3

104.07

141.37

umol/l

0.52

178

(3017354) Segmented neutrophils/Leukocytes in Blood

728

0.64

2.41

3.4

3.6

54.31

57.32

0.52

624

(3001019) Free T4 and TSH panel - Serum or Plasma

261

3131

0.83

2.39

1.7

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

548

1.43

2.38

1.6

1.5

34.93

31.07

0.37

334

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

857

0.67

2.37

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

733

6583

1.13

2.37

4.5

4.4

13.44

25.25

ug/l

1.43

599

5351

(3005719) IgG [Mass/volume] in Serum or Plasma

604

5364

1.14

2.34

3.6

2.9

10.44

10.45

g/l

0.01

570

4960

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

447

5117

0.86

2.34

4.3

1.22

1.23

mmol/l

0.79

393

4437

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4474

43479

1.08

2.32

3.3

3.4

49.44

47.57

u/l

0.61

4322

41006

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

219

1790

1.23

2.30

1.9

191.22

204.38

pmol/l

1.24

206

1697

(3010726) Horse dander IgE Ab [Units/volume] in Serum

167

1324

1.27

2.30

1.1

2.69

1.54

u/ml

0.74

712

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

2.45

2.27

1.0

161.46

164.75

g/l

0.34

(3014133) Dog dander IgE Ab [Units/volume] in Serum

145

1132

1.29

2.26

1.1

5.15

4.30

u/ml

0.21

594

(3008898) HLA-B27 [Presence]

275

2304

1.20

2.26

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

259

0.42

2.25

1.0

1.1

—

6.49

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

199

1615

1.24

2.25

1.2

1.1

1.20

2.14

u/ml

1.93

129

897

(3023430) Cat dander IgE Ab [Units/volume] in Serum

137

1063

1.29

2.25

1.1

4.33

5.23

u/ml

0.32

503

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

258

0.43

2.23

3.0

1.7

39.02

40.02

g/l

0.20

258

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

677

0.65

2.22

1.2

—

43.69

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

137

1066

1.29

2.20

1.6

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

175

1405

1.25

2.18

1.1

5.98

5.17

u/ml

0.16

111

778

(3020874) Milk IgE Ab [Units/volume] in Serum

483

1.43

2.18

1.1

1.2

2.25

2.96

u/ml

0.14

189

(3044927) Protein electrophoresis panel - Urine

601

0.63

2.17

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

119

911

1.31

2.17

1.2

1.3

405.51

315.59

pmol/l

0.47

107

775

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

845

7693

1.11

2.16

2.3

2.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

410

1.47

2.15

1.1

1.12

2.21

u/ml

0.33

127

(3002256) Pathology report gross observation

942

8636

1.10

2.11

1.4

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.05

2.10

1.3

1.0

—

(40768806) Pleura Pathology biopsy report

648

1.36

2.09

1.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

119

918

1.30

2.06

1.9

2.6

4.51

8.22

umol/l

3.26

679

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

199

1.66

2.04

1.5

1.4

480.36

422.34

mu/l

0.26

192

(44806420) Estimation of glomerular filtration rate

687

0.67

2.04

2.8

2.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

541

1.39

2.03

1.1

4.47

9.04

iu/ml

2.08

146

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.00

1.99

1.3

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

303

1.52

1.99

1.2

1.1

—

(4195642) Thrombophilia screening test

129

1013

1.28

1.97

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.28

1.97

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

353

1.48

1.95

1.4

1.5

27.70

34.17

nmol/l

1.11

318

(3003694) ABO and Rh group [Type] in Blood

2025

19247

1.07

1.90

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

514

1.38

1.90

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

227

1904

1.20

1.90

1.6

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

770

7030

1.11

1.89

2.2

2.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

251

1.56

1.88

1.3

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

348

1.47

1.88

1.8

1.7

9.77

6.11

nmol/l

0.18

274

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

204

1.62

1.88

1.5

1.4

68.91

74.32

1.04

197

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

448

1.41

1.87

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

189

1561

1.22

1.86

2.7

2.9

35.71

34.10

umol/l

0.42

166

1429

(1761482) Bacteria [#/volume] in Urine by Culture

110

1404

0.78

1.85

3.4

4.2

—

(40768443) Skin Pathology biopsy report

335

2910

1.16

1.85

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

100

767

1.31

1.85

1.4

0.36

0.40

g/l

0.85

563

(3006598) pH of Arterial cord blood

144

1.74

1.84

1.1

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

152

1229

1.24

1.84

1.6

0.92

0.77

g/l

0.59

124

970

(3027135) IgG subclass 1 [Mass/volume] in Serum

100

768

1.31

1.83

1.4

6.54

6.73

g/l

0.28

567

(3028192) IgG subclass 2 [Mass/volume] in Serum

100

768

1.31

1.83

1.4

2.76

2.88

g/l

0.39

569

(3028026) IgM [Mass/volume] in Serum or Plasma

470

4184

1.13

1.81

2.2

2.0

1.12

1.31

g/l

2.99

450

3877

(3022229) Phosphate [Moles/volume] in Urine

2.12

1.81

3.0

3.2

16.37

17.87

mmol/l

0.23

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.57

1.79

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

452

1.40

1.79

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

361

1.44

1.77

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.17

1.77

4.0

3.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

643

1.32

1.75

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

209

1.58

1.72

3.2

3.3

4.90

4.86

kpa

0.08

209

(3011985) Renin [Units/volume] in Plasma

124

988

1.26

1.72

1.3

1.5

140.53

63.66

mu/l

0.48

107

887

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

111

1399

0.79

1.71

3.1

3.7

1160.07

695.81

u/ml

0.19

1280

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

215

1815

1.19

1.71

1.2

4.46

4.08

0.16

233

(40765096) Chromosome analysis panel by Banding

216

0.46

1.70

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

398

1.41

1.70

2.2

2.6

41.86

39.87

0.33

218

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

210

1.57

1.69

3.2

3.3

10.87

10.27

kpa

0.48

210

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

123

983

1.25

1.67

1.1

0.10

0.33

u/ml

2.09

352

(3023419) Bacteria identified in Sputum by Culture

108

850

1.27

1.67

3.0

2.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

970

10415

0.92

1.66

1.7

1179.82

1156.66

nmol/l

0.36

801

7932

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.50

1.66

1.6

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2498

23997

1.06

1.66

3.8

33.70

72.54

ng/l

1.27

1649

16463

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

301

1.46

1.64

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

851

0.74

1.64

2.7

2.9

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

294

1.46

1.61

1.1

196.96

191.66

iu/ml

0.04

294

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

548

1.33

1.60

1.3

1.2

106.64

106.50

pmol/l

0.01

548

(3020876) Protein [Mass/time] in 24 hour Urine

105

830

1.27

1.58

2.5

0.99

1.32

g/24h

0.93

490

(3007566) Smooth muscle Ab [Titer] in Serum

227

1942

1.17

1.57

1.3

73.33

139.32

titre

1.26

177

(3003181) Sodium [Moles/volume] in Urine

151

1245

1.22

1.56

1.4

1.5

54.03

64.03

mmol/l

2.86

121

1012

(3000330) Specific gravity of Urine by Test strip

278

3183

0.87

1.55

3.0

3.3

1.02

ratio

0.87

246

2865

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1157

0.78

1.54

1.4

1.5

60.58

59.83

ug/l

0.07

1157

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.43

1.47

1.1

—

(3004775) Volume in Urine collected for unspecified duration

487

0.68

1.46

2.5

2.3

704.77

623.51

0.46

325

(3000034) Microalbumin [Mass/volume] in Urine

567

0.70

1.43

3.0

3.1

68.88

49.78

mg/l

0.14

428

(3009871) Measles virus Ab [Titer] in Serum

245

1.47

1.41

1.7

2417.78

2981.46

titre

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.17

1.39

1.4

1.5

331.50

344.72

umol/24h

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1206

0.80

1.39

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

2.00

1.37

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

347

1.38

1.37

5.9

6.2

40.50

631.64

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

349

3115

1.13

1.36

2.8

3.6

54.13

63.84

u/ml

0.24

340

3007

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

124

1020

1.22

1.36

1.1

1.2

123.45

114.86

2.07

118

925

(3034891) Synovial lining cells/cells in Synovial fluid

289

1.42

1.35

1.6

1.5

3.20

3.51

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

582

1.29

1.35

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

101

814

1.24

1.34

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

136

1133

1.20

1.32

1.9

1.7

—

(4015189) Microbial culture of sputum

146

0.48

1.31

1.1

2.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.50

1.30

1.2

1.1

—

(1002224) Polysomnography panel

354

3173

1.12

1.30

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

764

1.25

1.29

1.5

1.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.78

1.28

1.6

1.2

24.03

37.74

umol/24h

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.78

1.28

1.0

1.1

—

0.22

u/ml

—

(4062490) Immunoglobulin typing, IgG

758

1.24

1.26

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

186

1.51

1.25

1.0

1.2

—

(3049233) Organic acids panel - Urine

2.40

1.24

1.2

—

(3047181) Lactate [Moles/volume] in Blood

227

1986

1.15

1.23

5.8

6.2

1.37

1.30

mmol/l

0.33

200

1742

(3001964) Herpes simplex virus Ag [Presence] in Specimen

187

1.50

1.23

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

151

1282

1.18

1.21

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

151

1282

1.18

1.21

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

364

3286

1.11

1.20

1.5

1.4

22.35

25.42

iu/l

1.11

293

2761

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

148

1.55

1.19

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

418

1.32

1.18

1.2

1.4

4.04

4.86

umol/l

1.07

378

(3013727) Leukocytes other/Leukocytes in Blood

197

1.47

1.18

5.1

3.7

48.52

51.74

0.41

190

(40768793) Breast Pathology biopsy report

121

1441

0.84

1.17

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

497

4563

1.10

1.17

1.2

111.99

142.13

u/ml

1.19

173

1669

(3002079) Sodium [Moles/time] in 24 hour Urine

307

1.37

1.16

1.2

1.3

161.36

167.09

mmol/24h

0.20

307

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

140

1186

1.18

1.16

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

359

1.34

1.15

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

508

1.28

1.15

1.2

1.3

4.17

2.59

u/ml

0.32

296

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

1.15

0.0

1.3

—

3948.26

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.15

0.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

248

2196

1.13

1.14

1.6

1.5

10.74

9.19

u/l

0.90

188

1728

(3023487) Leukocytes [#/volume] in Peritoneal fluid

258

1.40

1.12

1.8

2.1

1197.05

3842.68

e6/l

0.40

176

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

128

1082

1.19

1.10

1.4

1.5

0.44

0.39

nmol/l

0.20

840

(3039000) Anion gap in Blood by calculation

157

1350

1.17

1.10

6.7

7.5

11.70

11.37

mmol/l

0.53

141

1206

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

230

2033

1.13

1.10

1.4

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

234

1.41

1.10

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

503

1.27

1.09

1.3

1.1

—

(3018572) Chloride [Moles/volume] in Blood

157

1351

1.16

1.09

6.7

7.5

104.76

105.03

mmol/l

0.27

141

1208

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.67

1.09

7.6

11.9

5.05

5.81

mmol/l

0.78

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

—

0.13

u/ml

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

109

910

1.20

1.08

1.5

3.34

4.36

ug/l

0.96

817

(21494755) Public health laboratory ask at order entry panel

559

6016

0.92

1.08

1.3

1.4

—

(3048879) Bone marrow aspiration report

163

0.55

1.08

2.8

2.0

—

2.00

—

(3034426) Prothrombin time (PT)

236

1.40

1.05

1.1

1.2

29.42

28.38

0.55

236

(3019832) Treponema pallidum Ab [Presence] in Serum

731

6854

1.07

1.05

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

312

2823

1.11

1.02

2.1

2.0

40.59

39.62

u/l

0.31

281

2532

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.91

1.02

1.1

2.5

—

(3010503) CD19 cells [#/volume] in Blood

404

0.72

1.01

3.9

2.6

250.21

287.68

e6/l

0.09

389

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

413

1.28

0.99

3.0

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

458

1.27

0.98

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

160

0.56

0.97

1.0

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

0.97

5.4

3.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.94

0.97

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

108

1.57

0.96

1.6

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

224

1.38

0.95

1.7

1.9

6569.14

15130.66

e6/l

0.38

116

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

577

1.23

0.95

3.1

2.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.76

0.94

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.65

0.94

1.5

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

108

916

1.18

0.93

1.5

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

119

0.50

0.93

1.7

2.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

114

972

1.17

0.93

5.7

6.8

11.35

11.78

mg/l

0.41

105

911

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

250

2250

1.11

0.93

5.6

6.0

1.51

1.48

mg/l

0.18

230

2091

(3036071) Salmonella sp Ab [Titer] in Serum

217

1.38

0.92

1.1

—

(3025130) Human papilloma virus identified in Specimen

111

945

1.18

0.92

1.9

—

(40768441) Liver Pathology biopsy report

508

1.24

0.91

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

110

1.55

0.90

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.07

0.89

1.2

1.1

0.08

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

236

1.36

0.89

1.1

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.79

0.87

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.00

0.87

1.0

1.3

995.77

450.29

nmol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

144

1.46

0.86

1.0

1.2

373.81

285.30

pmol/l

0.68

108

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

144

1.46

0.86

1.1

—

(3004451) EKG impression Narrative

380

0.74

0.86

1.2

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.78

0.84

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

514

1.23

0.84

3.3

2.7

622.07

523.75

e6/l

0.56

397

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.59

0.84

5.5

6.3

28.71

50.47

ug/min

1.12

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

816

1.18

0.83

2.6

2.5

13.68

29.35

iu/ml

—

(3035933) Granulocytes/Leukocytes in Blood

168

1490

1.13

0.82

3.5

3.3

55.04

57.54

1.74

168

1490

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

597

1.21

0.82

4.4

5.3

208.02

61.51

u/ml

0.46

191

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.74

0.82

2.9

3.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

115

1325

0.87

0.82

4.2

3.4

25.52

27.05

mg/l

0.19

905

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

562

1.21

0.81

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

562

1.21

0.81

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

562

1.21

0.81

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

325

2990

1.09

0.80

5.4

5.3

1.72

1.61

1.24

307

2827

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

164

1.40

0.79

2.0

1.8

0.21

0.19

nmol/l

0.10

122

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

430

0.77

0.79

1.5

1.4

—

(40758358) Immune stain study

0.00

0.79

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.67

0.78

6.5

5.4

107.63

101.67

g/l

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.1

—

0.05

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

163

0.61

0.78

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

225

1.33

0.77

1.8

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

134

1180

1.14

0.75

1.1

8.91

17.60

au/ml

1.73

270

(3023383) Lactate [Moles/volume] in Pleural fluid

183

1.37

0.75

1.0

1.4

4.22

3.37

mmol/l

0.57

165

(3008757) Leukocyte morphology finding [Identifier] in Blood

680

0.82

0.75

4.6

4.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

368

1.25

0.75

3.0

1.9

7.88

7.97

mmol/l

0.06

368

(3042517) Benzodiazepines panel - Urine

1.64

0.75

6.4

2.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

210

2313

0.90

0.74

1.8

1.7

3.87

4.45

mg/l

0.33

159

1706

(21494815) CD4 cells/Lymphocytes in Specimen

642

1.18

0.73

3.3

2.5

39.89

38.59

0.35

631

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.00

0.72

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

153

1364

1.12

0.72

2.5

2.0

0.81

0.85

nmol/l

0.32

132

1168

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

110

960

1.15

0.71

1.1

1.48

1.51

g/l

0.33

105

879

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

151

1.39

0.70

1.4

2.3

15.42

16.63

umol/l

0.21

151

(3045142) Bone marrow Pathology biopsy report

785

1.16

0.70

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

421

0.78

0.70

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

363

1.24

0.69

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

108

944

1.15

0.69

1.1

2.89

3.89

eliau/ml

0.32

426

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

389

3635

1.07

0.68

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

301

1.26

0.68

1.7

1.6

1.35

3.15

u/field

1.52

219

(40758292) HTLV I+II Ab panel - Serum

135

1.41

0.68

1.4

1.3

—

(3017509) Phencyclidine [Presence] in Urine

1.64

0.68

1.1

1.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

383

1.23

0.67

11.9

13.5

0.66

0.61

mmol/l

0.85

347

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

133

1491

0.89

0.67

1.6

—

(40763590) HLA-DQ beta [Type]

1.78

0.66

1.2

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.78

0.66

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

658

0.83

0.66

2.7

2.4

1.18

1.20

mmol/l

2.69

647

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

294

0.75

0.66

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

294

0.75

0.66

1.6

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

632

1.17

0.65

2.9

3.5

12.20

13.48

index

0.82

389

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

661

1.17

0.64

1.2

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

477

1.20

0.64

1.3

1.1

—

1.46

—

(46236302) HLA-C [Type] by High resolution typing

1.72

0.63

1.2

1.0

—

(3013862) HLA-DP [Type]

1.72

0.63

1.2

1.0

—

(40760409) HLA-A [Type] by High resolution

1.72

0.63

1.2

1.0

—

(40760410) HLA-B [Type] by High resolution

1.72

0.63

1.2

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

163

1.35

0.63

1.2

1.3

39.45

15.77

u/ml

0.40

115

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

601

0.83

0.63

2.5

2.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

131

1169

1.12

0.63

3.3

0.79

0.81

nmol/l

0.14

113

943

(3028433) Virus identified in Specimen by Culture

235

0.72

0.63

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

496

1.19

0.63

1.9

1.6

24.07

22.35

u/ml

0.14

(3041096) Erythrocytes [Presence] in Urine by Automated

1906

18579

1.03

0.63

3.3

0.04

0.13

estimate

0.78

545

5684

(4035726) Immunohistochemistry procedure

537

5655

0.94

0.63

1.4

—

(40757373) Influenza virus identified in Isolate

112

1.43

0.63

1.3

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

120

1068

1.12

0.61

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.5

—

44.17

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.48

0.60

17.8

13.7

0.33

0.39

umol/l

0.34

(3033086) Enterovirus Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

165

1.33

0.60

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

191

1748

1.09

0.59

2.1

2.0

12.20

11.64

mg/l

0.53

181

1643

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

1.2

—

0.20

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

110

978

1.13

0.58

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

112

0.62

0.58

2.4

2.9

16.14

14.75

ml/dl

—

105

(3017704) Immunofixation for Urine

330

0.79

0.56

2.1

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.45

0.56

2.3

1.7

32.26

44.96

umol/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.56

0.55

1.0

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

294

2749

1.07

0.55

5.7

5.6

0.90

0.87

0.57

275

2596

(3038071) Oxygen [Partial pressure] in Mixed venous blood

177

1.30

0.54

6.8

6.9

5.46

5.34

kpa

0.11

177

(3034988) Calcium [Moles/volume] in Capillary blood

151

1.32

0.53

1.5

3.3

1.17

1.19

mmol/l

1.53

144

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

126

1.35

0.51

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

269

1.23

0.50

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

715

1.13

0.50

1.7

1.6

58.41

57.62

0.07

454

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

687

1.14

0.50

1.5

1.8

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.46

0.50

1.2

1.7

12.77

21.74

pmol/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

118

1.36

0.50

1.1

0.60

0.70

umol/24h

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

529

1.15

0.49

3.7

2.8

231.29

224.38

e6/l

0.08

429

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

107

0.65

0.48

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

103

927

1.11

0.47

1.6

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

677

0.87

0.47

2.6

2.3

3.95

4.07

mmol/l

1.28

666

(3035285) Chloride [Moles/volume] in Venous blood

677

0.87

0.47

2.6

2.3

106.08

105.42

mmol/l

0.54

666

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.49

0.47

1.6

2.1

—

(3045414) Leukocytes [Presence] in Urine

610

6342

0.96

0.47

2.0

2.1

0.04

0.01

estimate

0.52

141

1375

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

281

1.21

0.47

3.9

2.9

0.97

1.32

ug/l

0.72

265

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

135

1234

1.10

0.46

1.6

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

221

0.77

0.46

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.43

0.46

1.6

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

168

1553

1.08

0.45

1.2

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

103

1.36

0.45

1.9

18.21

38.98

pmol/l

1.46

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

174

1.26

0.44

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

302

1.19

0.43

1.5

2.0

174.40

185.80

ug/min

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

140

0.71

0.43

2.5

2.6

4.90

257.94

ug/l

—

140

(3034092) Cytoplasmic Ig cells/cells in Blood

1.41

0.43

8.2

9.6

0.22

0.20

0.31

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

257

1.21

0.42

3.3

4.5

8.66

8.62

mg/l

0.01

214

(3024471) HLA-A [Type]

230

1.22

0.42

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.40

0.42

1.1

1.2

2.07

1.68

umol/24h

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

140

1.29

0.41

2.7

2.4

0.95

1.74

mmol/l

1.75

101

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

194

1.24

0.41

1.3

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

206

0.78

0.41

1.4

1.6

0.44

0.49

e9/l

0.56

206

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

11.64

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

0.41

0.0

9.2

—

55.33

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

370

1.16

0.40

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

100

910

1.10

0.40

1.5

1.6

—

(4212803) Bone marrow aspirate examination

1.31

0.39

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

251

1.20

0.38

5.3

4.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

124

1.29

0.38

6.6

7.5

9.81

10.46

0.59

124

(3012494) Peanut IgE Ab [Units/volume] in Serum

233

1.20

0.38

1.1

1.2

0.75

28.66

u/ml

1.06

142

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.39

0.38

1.0

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.35

0.37

1.1

1.4

—

(3017732) Neutrophils [#/volume] in Blood

817

8397

0.97

0.37

2.9

3.2

5.17

4.59

e9/l

0.61

766

7306

(3022806) Fractional oxyhemoglobin in Capillary blood

788

0.90

0.37

2.0

1.9

90.71

89.70

1.07

774

(3021440) Promyelocytes/Leukocytes in Blood

553

5721

0.96

0.37

5.2

4.7

0.10

0.12

0.19

163

1586

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

223

0.81

0.35

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.64

0.35

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

190

0.79

0.35

2.0

1.6

10.31

9.01

ug/l

0.44

190

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.33

0.35

1.5

1.6

—

14.70

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.43

0.35

1.0

—

(3024932) HLA-DR beta [Type]

226

1.19

0.35

1.2

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

125

1346

0.93

0.35

1.3

1.5

107.51

165.68

pmol/l

1.70

125

1315

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.35

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

193

2043

0.94

0.34

1.5

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.34

0.34

1.0

4.79

6.61

u/ml

0.25

(3000012) Reticulocyte production index

949

0.92

0.33

2.8

2.1

0.92

0.90

0.15

625

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.30

0.33

1.2

1.1

4.13

10.29

u/ml

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

296

0.84

0.33

1.2

10.36

9.58

mm/h

0.14

296

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.28

0.32

6.8

5.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

257

1.17

0.31

1.4

1.2

1300.00

1038.18

titre

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

389

1.13

0.31

1.1

1.39

1.14

u/l

0.84

175

(3037121) Protein [Mass/volume] in Urine

217

2281

0.95

0.31

3.0

3.7

969.24

424.50

mg/l

0.39

115

1103

(44806071) Cardiolipin IgM antibody measurement

0.72

0.30

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

100

0.70

0.30

2.0

2.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

191

1810

1.06

0.30

2.0

3.44

6.88

iu/l

0.56

759

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.33

0.30

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

807

0.92

0.30

2.3

1.9

5893.33

1364.21

titre

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

166

1.20

0.29

1.4

1.6

0.41

0.38

ug/l

0.06

115

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

323

3104

1.04

0.29

1.5

1.6

954.23

1006.29

mu/l

0.47

261

2620

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

220

2306

0.95

0.29

1.1

0.65

0.64

ratio

0.10

284

(1616796) Gas panel - Central venous blood

141

1497

0.94

0.29

3.7

4.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

104

1116

0.93

0.29

3.5

3.7

1.82

1.61

0.19

995

(3011412) CD3 cells [#/volume] in Blood

717

1.09

0.28

3.3

2.5

1252.37

1217.49

e6/l

0.12

608

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

449

1.11

0.28

1.1

1.0

244.51

324.05

ng/l

3.50

319

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

232

1.16

0.28

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

119

1114

1.07

0.28

1.5

1.9

4.33

4.91

mmol/24h

1.49

111

991

(4281824) Cell count and differential, peritoneal fluid

658

0.91

0.28

1.3

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

557

5721

0.97

0.27

4.8

4.5

0.47

0.71

2.53

188

1762

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

438

0.89

0.27

1.7

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

806

1.08

0.27

1.4

1.7

291.33

346.44

mu/l

1.48

643

(3038177) Helicobacter pylori Ab [Presence] in Serum

113

1058

1.07

0.27

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

131

1.22

0.27

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

131

1.22

0.27

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

131

1.22

0.27

1.0

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

113

1203

0.94

0.26

1.3

33.56

36.78

u/l

0.13

106

1044

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.70

0.26

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

0.69

0.26

1.4

212.00

170.82

mmol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

376

1.12

0.26

1.1

1769.45

1486.56

miu/ml

0.85

376

(3027035) Albumin [Mass/time] in 24 hour Urine

0.68

0.26

1.4

1.3

—

577.74

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.30

0.26

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

288

0.87

0.25

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

330

0.88

0.25

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

330

0.88

0.25

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

330

0.88

0.25

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

330

0.88

0.25

2.0

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

1.17

0.25

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

298

0.87

0.25

1.7

1.9

6.04

3.46

u/ml

—

(3014891) Appearance of Pleural fluid

0.74

0.24

1.2

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.74

0.24

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

161

1.18

0.24

1.3

37.50

36.48

0.05

110

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

312

1.12

0.23

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

379

1.11

0.23

6.5

7.1

27.24

122.52

ug/l

0.91

250

(3008536) Aspergillus sp Ab [Presence] in Serum

134

1.19

0.22

2.7

2.1

—

(3016228) CD19 cells/cells in Blood

274

0.87

0.22

2.9

2.1

11.08

8.28

0.38

263

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

917

0.94

0.22

1.3

1.4

24.11

25.33

u/l

0.15

759

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.76

0.22

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.25

0.22

1.0

—

(3051339) Copper [Moles/volume] in Blood

1.25

0.22

1.2

18.12

16.34

umol/l

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

0.01

0.19

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

223

2144

1.04

0.22

1.3

208.92

222.61

miu/ml

0.24

966

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

242

0.87

0.22

2.0

2.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

335

3247

1.03

0.22

2.2

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

167

0.84

0.21

1.0

29.92

36.95

iu/ml

0.31

167

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

516

1.09

0.21

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

0.17

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

6.1

—

0.28

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

2.40

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

241

0.87

0.21

2.0

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

241

0.87

0.21

2.0

2.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.21

0.0

3.7

—

138.50

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

237

2452

0.96

0.20

1.7

1.6

11.23

14.62

u/ml

0.50

590

(3047007) Chlamydophila sp Ab [Presence] in Serum

104

984

1.06

0.20

1.2

—

(3020650) Glucose [Presence] in Urine

229

0.87

0.20

1.5

1.7

0.15

0.03

estimate

0.37

229

(3029396) Erythrocyte agglutination [Presence] in Blood

183

1.15

0.20

3.1

3.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

432

1.09

0.19

1.2

0.54

0.59

ratio

0.82

251

(3010375) cycloSPORINE [Mass/volume] in Blood

354

0.90

0.19

32.4

29.0

113.88

118.83

ug/l

0.24

293

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

452

1.08

0.19

1.1

1.0

808.57

718.43

ng/l

0.61

314

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

118

1.19

0.19

3.9

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

217

0.87

0.18

2.7

2.1

2.21

1.74

ratio

0.44

207

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.23

0.18

1.4

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

812

1.06

0.18

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

280

1.11

0.18

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

309

1.10

0.18

1.2

4.7

89.44

813.22

mg/l

0.48

224

(4133840) Spirometry

166

1.14

0.17

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

454

1.08

0.17

1.1

1.0

32.66

43.38

ng/l

2.41

318

(3045683) HLA typing for celiac disease panel - Blood or Tissue

393

0.91

0.17

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

464

1.08

0.17

2.2

2.0

1.41

1.50

u/field

0.10

252

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

485

0.93

0.17

1.2

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.22

0.17

1.0

1.1

0.16

0.76

u/ml

—

(3007916) DNA double strand Ab [Titer] in Serum

0.76

0.17

1.2

1.4

—

110.27

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.76

0.17

1.0

1.2

—

23.23

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

526

0.93

0.17

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

183

0.87

0.16

1.1

—

(40768795) Lymph node Pathology biopsy report

642

1.06

0.15

1.3

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.77

0.15

1.5

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.14

0.15

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

129

1339

0.96

0.15

1.9

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

129

0.85

0.14

1.4

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

116

1114

1.04

0.14

1.1

122.59

10331.71

iu/ml

0.61

253

(3012501) Base excess in Blood by calculation

139

1341

1.04

0.14

3.7

4.6

2.42

2.53

mmol/l

0.16

904

(3025159) Blasts/Leukocytes in Blood

571

5796

0.98

0.14

5.5

4.9

0.41

0.33

0.07

171

1518

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

170

1752

0.97

0.14

1.1

2.81

7.92

eliau/ml

2.63

225

(42529582) MDA5 Ab [Presence] in Serum by Line blot

191

0.89

0.14

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

191

0.89

0.14

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

191

0.89

0.14

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

191

0.89

0.14

1.0

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

274

0.91

0.14

2.8

2.1

33.68

30.87

0.32

274

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.19

0.13

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

499

1.06

0.13

1.2

1.1

18.14

18.03

u/ml

0.01

199

(3005011) Chlamydia sp Ab [Titer] in Serum

0.83

0.13

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

295

1.08

0.13

1.2

1.1

317.09

386.07

ng/l

0.08

(3028717) Thiamine [Mass/volume] in Blood

100

0.80

0.13

1.0

1.3

69.88

66.56

ug/l

—

100

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

132

1.14

0.13

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

171

1.11

0.12

1.4

1.3

511.79

381.96

ug/l

—

(3002619) Bacteria identified in Specimen by Culture

168

0.89

0.11

1.1

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

230

0.91

0.11

1.2

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

761

0.96

0.11

10.2

13.7

7.21

7.18

mmol/l

0.02

644

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

201

1.09

0.11

1.3

1.1

—

(21494434) Karyotype in Bone marrow

618

0.95

0.11

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

525

0.95

0.10

4.0

2.7

22.83

30.31

mg/l

1.17

378

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

870

0.96

0.10

1.3

7.44

7.23

mmol/l

0.29

777

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

391

0.95

0.09

1.8

1.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.04

0.09

1.0

—

(44813793) Dust mix specific IgE antibody measurement

482

0.95

0.09

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

233

1.07

0.08

3.1

3.4

224.35

116.91

au/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

429

1.05

0.08

1.4

1.5

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.03

0.08

1.3

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

107

1.12

0.08

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

204

2076

0.98

0.08

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.83

0.08

1.0

1.1

18.02

16.08

g/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

240

2438

0.98

0.08

1.1

1.48

1.52

g/l

1.38

240

2438

(3010144) Erythrocytes [#/volume] in Synovial fluid

592

0.96

0.08

1.3

1.4

122836.13

103292.05

e6/l

0.09

404

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.03

0.07

1.0

1.1

0.02

0.03

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

793

0.97

0.07

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.08

0.07

1.1

1.2

1.01

0.26

u/ml

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

347

0.95

0.07

1.5

—

1389484.39

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.84

0.07

1.9

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.83

0.07

1.4

1.8

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

363

1.05

0.07

4.3

2.2

189.55

199.47

u/l

0.62

358

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

407

0.96

0.07

24.3

20.2

1252.77

1389.27

nmol/l

0.59

393

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.87

0.06

1.5

1.3

69.63

65.63

ug/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

132

0.91

0.06

1.4

1.1

—

(4211845) Urine protein measurement

315

0.95

0.06

1.5

3.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

103

0.87

0.06

1.2

2.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

118

1203

0.98

0.06

1.3

328.00

378.67

titre

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

948

1.02

0.06

1.1

1.93

2.90

0.54

151

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

405

0.96

0.05

1.2

1.09

1.06

ratio

0.44

325

(3020191) Ethanol [Moles/volume] in Serum or Plasma

586

0.97

0.05

1.4

1.5

1.34

1.19

promille

0.30

465

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

149

1.07

0.05

1.3

—

(40768446) Kidney Pathology biopsy report

287

1.04

0.05

2.1

1.8

—

(3022621) pH of Urine by Test strip

523

5191

1.01

0.05

2.6

6.16

6.08

1.37

390

3464

(3043410) Blood group antigens tested for on Red Blood Cells

169

1.06

0.05

2.3

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

219

1.05

0.04

1.2

1.3

85.75

85.68

0.00

111

(3006442) Creatine [Moles/volume] in Serum or Plasma

427

1.03

0.04

1.9

1.4

85.55

81.46

umol/l

0.26

427

(3024263) Appearance of Synovial fluid

338

1.03

0.04

1.3

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

311

0.96

0.04

3.7

4.3

—

(3017181) Myelocytes/Leukocytes in Blood

602

5987

1.01

0.03

5.0

4.7

0.91

0.94

0.11

212

1847

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

411

0.97

0.03

1.7

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

265

2632

1.01

0.02

2.3

6921.72

5616.58

u/l

0.27

1036

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

560

0.98

0.02

1.2

1.1

321.86

265.04

mg/l

0.92

491

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

202

1.04

0.02

1.3

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

579

0.98

0.02

1.2

1.1

49.73

40.57

mg/l

0.74

480

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

680

1.01

0.02

1.1

—

(40768800) Prostate Pathology biopsy report

131

1319

0.99

0.01

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

392

1.02

0.01

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

437

0.98

0.01

1.5

1.7

13.97

21.63

umol/l

2.53

409

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

356

0.98

0.00

1.4

1.6

282.60

411.34

pmol/l

—

(3008295) Osmolality of Serum or Plasma

776

0.99

0.00

1.6

1.4

283.48

279.25

mosm/kgh2o

0.93

595

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

646

6448

1.00

0.00

3.2

3.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

146

1454

1.00

0.00

2.3

2.4

81.54

107.24

ug/min

0.49

891

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

499

1.00

0.00

1.5

1.3

340.60

165.66

pmol/l

0.47

499

(1617658) Protocol used for examination of sentinel lymph nodes

425

1.01

0.00

1.1

—

(3017569) Oxygen content in Arterial blood

379

1.00

0.00

3.5

2.1

16.33

16.15

0.13

379

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

168

1.01

0.00

2.3

3.0

173.83

135.97

ng/l

0.24

106

(3033099) Centromere Ab [Titer] in Serum

147

1.02

0.00

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

111

0.99

0.00

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

0.97

0.00

1.4

1.6

—

(3006462) Nitrate [Presence] in Urine

283

0.99

0.00

1.5

3.5

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

133

0.98

0.00

4.8

6.3

9.15

7.82

0.41

133

(40761995) Spermatozoa Progressive [#/volume] in Semen

133

0.98

0.00

2.4

3.2

35.15

43.44

0.85

133

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

143

0.98

0.00

1.2

1.3

1.16

1.17

mmol/l

0.20

143

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

150

1.00

0.00

1.7

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

545

0.99

0.00

1.7

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

584

0.99

0.00

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

224

0.98

0.00

1.2

1.1

87.40

88.42

—

111

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

185

0.97

0.00

1.3

34.05

13.56

pmol/l

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.1

—

192.63

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1466.25

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.43

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.91

-0.00

5.8

3.9

—

(3051101) Glucose [Moles/volume] in Cord blood

0.98

-0.00

3.1

7.0

7.81

8.12

mmol/l

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.89

-0.00

1.5

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.2

—

15.00

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.93

-0.00

1.0

1.1

12.20

15.11

u/l

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.93

-0.00

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.97

-0.00

1.5

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.92

-0.00

1.0

1.1

90.67

96.00

titre

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_VIRAL_HEMOR_FEVER_NOS_WIDE – Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo (AB1_VIRAL_HEMOR_FEVER_NOS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints